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Autism is known as a heritable neurodevelopmental disorder, diagnosed prior to the age of three years 
in humans based on three major domains: (1) impairment in social interaction (2) communication 
deficits (3) restricted interests and repetitive behaviors. Since it is a very heterogeneous disorder with 
various causes and different combinations of phenotypes, it is also called autism spectrum disorder 
(ASD). Monogenic heritable forms of ASD enable us to develop genetic mouse models of autism in 
order to obtain mechanistic insight in this disorder. 
Ambra1 is a positive regulator of Beclin1, a major player in the formation of autophagosomes during 
the process of autophagy. While Ambra1 null mutation leads to embryonic lethality, we could show 
that Ambra1 heterozygous mice (Ambra1+/-) display autism-like behavior only in females. Purpose of 
this thesis was therefore to characterize this mouse line further.  
It turned out that communication deficits, measured by ultrasound vocalization, start in the neonatal 
stage of females, while physical or neurological development is normal in Ambra1+/-. Female Ambra1 
mutants had a stronger reduction in Ambra1 expression than male mutants, which gives first hints of 
the female-specific autism-like behavior in this mouse line. Mild enlargement of whole brain and 
hippocampus was detected in both Ambra1+/- males and females, with no change of ventricle size. 
Since β-galactosidase, used as reporter expressed under the Ambra1 promoter, was found only in 
neuronal cells, I focused on understanding the neural mechanism of its phenotype.  
Short-term and long-term synaptic plasticity in the hippocampus was normal for males and females of 
both genotypes. However, the power of gamma oscillations (γ-power), indicative of change in the 
balance of excitation and inhibition, was age-dependently altered in Ambra1+/- females only. However, 
this difference was not detected in male. Moreover, increased susceptibility to seizures, a known 
comorbid condition of ASD was restricted to females, suggesting an association between autism-like 
behavior, gamma oscillation and seizure propensity in female Ambra1+/- mice.  
Next, I approached the neuronal substrate of these three phenotypes by morphological analysis of 
hippocampal pyramidal neurons, such as dendritic arborization and synapse number. A genotype-
associated difference of dendritic arborization was detected in neither males nor females. The 
quantification of spines or synapses and cellular electrophysiology are still on-going. First signals point 






1.1 Autism spectrum disorder 
‘’The Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V)’’ defined autism 
spectrum disorder (ASD) as a group of heterogeneous neurodevelopmental disorders which is 
diagnosed prior to the age of three years in humans based on three main domains: (1) deficits in 
social interaction, (2) a lack of appropriate language and communication skills, and (3) repetitive 
behaviors and stereotypies (Association, 2013).  
1.1.1 Genetics of autism spectrum disorder 
Epidemiological research on twin and family studies has provided evidence of a strong genetic 
component in ASD etiology. Epidemiological studies estimated that more than 1% of the world’s 
population have received a diagnosis of ASD (Christensen et al., 2016; Elsabbagh et al., 2012). The 
recurrence risk in families with infants having an affected older sibling was approximately 20% 
(Ozonoff et al., 2011). One twin study revealed the concordance rate in monozygotic twins to be 82-
92%, in dizygotic twins as the rate was more than 20%, supporting ASD as genetic neuropsychiatric 
disorder. The heritability of autism has been estimated to be 70-80%, implying that a possibility of 
environmental effect but still a strong genetic cause in ASD (Bailey et al., 1995; Colvert et al., 2015; 
Frazier et al., 2014; Hallmayer et al., 2011; Schendel et al., 2014).  
In the 1990s, genetic factors of ASD were first reported in monogenic disorders, such as fragile X and 
Rett syndromes (Pieretti et al., 1991; Zoghbi et al., 1999) and later as chromosomal abnormalities in 
family studies (Vorstman et al., 2006). Several candidate genes encoding for synaptic proteins, such 
as NLGN3, NLGN4X, NRX1 and SHANK3, were identified to be mutated in patients diagnosed with 
ASD (Durand et al., 2007; Jamain et al., 2003; Szatmari et al., 2007). Another group of genes 
encoding for translational proteins, such as TSC1/TSC2, NF1 or PTEN, were recently found mutated 
in a number of ASD patients (Goffin et al., 2001; Gutierrez et al., 1998). Exploring the role of mutated 




1.1.2 Sex differences in autism spectrum disorder 
The prevalence of sexually dimorphic diseases is well known, but poorly understood. While several 
disorders related with autoimmunity, like multiple sclerosis and systemic lupus erythematosus, are 
female-dominant (Whitacre, 2001), neurodevelopmental disorders such as attention deficit 
hyperactivity disorder and language impairment show male-dominance (Barbaresi et al., 2002; 
Szatmari et al., 1989; Viding et al., 2004). ASD has been described as a sexually dimorphic disease, 
since they are diagnosed more often in males than females (4:1, male to female ratio). This 
observation of sex-specific biological factors in ASD etiology has been consistent across time and 
populations. There has been no sex-dependent difference found in overall severity of ASD measured 
by a variety of assessment tools (Kopp and Gillberg, 2011; Lai et al., 2012, 2011). Among many 
possible hypotheses about the male-dominance in autism, two biological connections have been 
implicated: genetic perturbation and hormonal regulation. 
It is widely accepted that children who are exposed to high levels of testosterone in the womb show 
similar results in psychological tests to people with ASD, called the fetal testosterone (fT) theory. And 
it is the major explanation of sexual hormonal effect on the sex bias in ASD (Baron-Cohen et al., 2004). 
In the general population, sexual dimorphism of social domains has been associated with fT level, 
implying an effect of fT on the development of social behaviors (Knickmeyer et al., 2005, 2006, 
Lutchmaya et al., 2001, 2002). fT has not been the only hormone implicated in ASD phenotypes. 
Estrogen and oxytocin have been discussed as causes of ASD (Auyeung et al., 2015; Crider et al., 
2014; Hoffman et al., 2016; Jones and Okere, 2008; Liu et al., 2015; Sarachana et al., 2011; Sharpe 
et al., 2013; Yatawara et al., 2015). 
The main alternatives to the fT theory are the X and Y chromosome theories. Fragile X mental 
retardation 1 (FMR1) gene, where 46% of male and 16% of females carrying the full mutation were 
also diagnosed with ASD, is the best example of X chromosome effect on ASD (Bailey et al., 2008). 
One study reported higher autistic traits score in girls with Turner syndrome (characterized by the XO 
karyotype) (Tartaglia NR, Hansen RL, Reynolds A, Hessl D, 2006). As the XXY and XXYY syndromes 
have increased incidence of ASD (Bruining et al., 2009; Geerts et al., 2003; Tartaglia et al., 2008), it is 
also important to consider if the male bias in ASD result from the male-limited expression of genes on 




autism and his father with learning difficulties (Jamain et al., 2003). All three theories might not be 
mutually exclusive, because all those factors can regulate or influence each other (Baron-Cohen et al., 
2011). 
1.1.3 ASD and Brain enlargement 
Studies of neuroimaging and postmortem examinations in human autists have reported the structural 
abnormalities in whole brain or sub-regions of the brain (Chen et al., 2016; Courchesne and Pierce, 
2005; Hazlett et al., 2011; Haznedar et al., 2000; Piven et al., 1998; Saitoh et al., 1995; Schumann et 
al., 2004). In spite of inconsistency across all studies, a majority of research has shown an increase in 
whole brain or sub-regions, such as cortex or hippocampus, in autist brains (Courchesne and Pierce, 
2005; Courchesne et al., 2003, 2011; Hazlett et al., 2011; Schumann et al., 2004).  
One study showed that at the age of two or three years, 90% of autist toddlers had enlarged brain 
volumes, especially cerebral gray and white matter and cerebellar white matter, than average of 
normal toddlers (Courchesne et al., 2001). This enlargement of brain and cerebrum in young autists 
was replicated independently in a study of 3 to 4-year old children, showing larger volume of whole 
brain, cerebrum, cerebellum and amygdala in autists compared to normal children (Sparks et al., 
2002). The growth rate of the brain was slower in older autists than normal children, especially in gray 
matter (Courchesne et al., 2001), which result in normal or reduced volumes in limbic or cerebral 
structures in autistic adults (Bigler et al., 2003; Courchesne et al., 2001; Herbert et al., 2003; Kates et 
al., 2004; Lotspeich et al., 2004). Although the cellular bases of the early growth pathology in autism 
are unclear, this enlargement might be due to excess number of neurons in the prefrontal cortex 
(Courchesne et al., 2011) or increased number of synapses (Tang et al., 2014). 
1.1.4 Comorbidity of seizure in autism 
One of the relatively common comorbid conditions in autism is epilepsy. Epilepsy is defined as a brain 
disorder characterized by the predisposition to generate epileptic seizures due to abnormal, excessive, 
or synchronous neuronal activity in the brain and by neurobiological, cognitive, psychological and 




The risk of epilepsy in patients with ASD is increased but variable. A wide range of prevalence rates 
have been reported, from 5 to 40%, probably due to the heterogeneity in the clinical study with respect 
to diagnosis, age, and mental level (Elia et al., 1995; Giovanardi Rossi et al., 2000). Comparison the 
prevalence of epilepsy in autistic children and all children, approximately 2-3%, indicates high 
association of epilepsy in autism. Around 60% of human autists without history of epilepsy showed 
abnormal electroencephalogram (EEG) activity during sleep (Chez et al., 2004). 
Previous studies suggested two peaks in the onset of seizures in autism; early childhood and 
adolescence (Volkmar and Nelson, 1990). The rate of epilepsy in pre-adolescent autists was less than 
10% (Fattal-Valevski et al., 2007; Hoshino et al., 1987; Voigt et al., 2000), while in adolescent or adult 
autists were as high as 39% (Giovanardi Rossi et al., 2000; Kawasaki et al., 1997).  
A common genetic basis has been proposed to speculate on the comorbidity of seizure and autism. In 
humans SYN1, an X-linked gene encoding a neuron-specific phosphoprotein which regulates 
neurotransmitter release and synaptogenesis, is a predisposing gene to ASD as well as epilepsy 
(Fassio et al., 2011). Furthermore, the R451C missense mutation in the NLGN3 gene was identified in 
two siblings with ASD, one with comorbid epilepsy (Jamain et al., 2003). 
1.1.5 Genetic mouse model of autism 
The etiology of ASD has been still unclear, since this disorder has heterogeneous severity as well as 
causes. Previously, the animal models based on face validity were used in ASD studies searching for 
pharmacological therapy (predictive validity), but there was no effective treatment paradigm for the 
core symptom of human ASD (Hulbert and Jiang, 2016). Recently, monogenic heritable forms of ASD 
enable us to develop the genetic mouse model of autism with construct validity (Betancur et al., 2009; 
Jamain et al., 2008; Tabuchi et al., 2007). Most of the described mechanisms of ASD phenotypes 
come from detailed characterization of mouse models of syndromic autism, where the genetic cause is 
clearly defined.  
1.2 Ambra1 
Ambra1 is an activating molecule in Beclin-1-regulated autophagy (Ambra1) and plays a crucial role in 
the regulation of Beclin1 which is a key modulator of autophagosome formation during autophagic 




serine-rich domains and dynein binding domains. Importantly, protein containing WD40-domains 
function as coordinators of multi-protein complex assembly and provide a rigid scaffold for protein-
protein interactions. Ambra1 was first found as a binding partner of Beclin1. More recently, other 
interaction partners of Ambra1 such as mitochondrial Bcl-2, ULK1, PP2, and DLC1/2 have been 
described, indicating multiple, distinct functions of Ambra1 in eukaryotic cells (Cianfanelli et al., 2015a). 
The Ambra1 gene is located on mouse chromosome 2 and human chromosome 11 and is composed 
of 18-19 exons (Maria Fimia et al., 2007). 
1.2.1 Mutation of Ambra1 
 
Figure 1. Neural tube defects in Ambra1-/- embryos 
A, B: Embryos of Ambra1+/+ (A) and Ambra1-/- (B) at E14.5; the homozygosity of the Ambra1 mutation 
is characterized by prominent exencephaly (Ex) in the embryos, which results in embryonic lethality. C, 
D: Electron scanning microscopic analysis of Ambra1-/- embryos at E11.5 (C) and E12.5 (D); failure of 
the neural tube closures, extensive midbrain/hindbrain exencephaly with a closed telencephalon (T), 
and lumbosacral spina bifida (Sb) were detected. E, F: Histological analysis of Ambra1+/+ (E) and 
Ambra1-/- (F) cross-section of embryonic brains at E12.5; Ambra1-/- embryos exhibits the absence of a 
normal ventricular system due to the extensive overgrowth of the proliferative neuroepithelium in the 
diencephalon (Di) and spinal cord (Sc). Presence of an enlarged fifth ganglia (VG) was also evident in 
the Ambra1-/- embryo. Scale bars; A, 2 mm; C-E, 500 μm. Adapted with permission from Nature 





The mouse mutation of Ambra1 was generated by gene trapping mutagenesis. This is done by 
inserting a gene trap vector containing a lacZ reporter gene into intron 11, which produces a truncated, 
non-functional Ambra1 protein. However, the homozygous Ambra1 mouse mutant (Ambra1-/-) is 
embryonic lethal in outbred or inbred genetic backgrounds. At embryonic day (E)10-14.5, most of the 
Ambra1-/- embryos had neural tube defects such as midbrain/hindbrain exencephaly and/or spina 
bifida. In the forebrain of embryonic Ambra1-/- mice, closed but displaced vesicles, extensive 
overgrowth of neuroepithelium, and enlarged spinal cords were found (Fig 1. A-F). Neural tube defect 
in the deficiency of Ambra1 in mouse embryos might be associated with autophagy impairment, 
excessive cell proliferation and apoptosis and accumulation of ubiquitinated proteins in the 
neuroepithelium. The embryonic expression of Ambra1 was found throughout the neuroepithelium at 
E8.5 and detected in the ventral-most part of the spinal cord, the encephalic vesicles, the neural retina, 
the limbs, and the dorsa root ganglia at E11.5. Ambra1 is later expressed throughout the entire 
developing nervous system (Maria Fimia et al., 2007). 
1.2.2 Function of Ambra1 
As previously mentioned, recent binding assays discovered more potential binding partners of Ambra1, 
implicating the possibility of multiple functions of Ambra1. 
1.2.2.1 Role of Ambra1 on the autophagic pathway 
Under basal conditions, Ambra1 is bound to the dynein light chains 1/2 (DLC12) of the dynein motor 
complex, together with Beclin1 and PI3KIII. After autophagy induction, Ambra1 is released from the 
dynein complex by ULK1-mediated phosphorylation, resulting in translocation of Ambra1 still bound to 
Beclin1 and Class III Phosphoinositol-3-kinase complex (PI3KIII), to the endoplamic reticulum (ER) 
where the formation of autophagosomes are initiated (Cianfanelli et al., 2015a). Recently, Ambra1 was 
shown to regulate the activity and stability of ULK1, suggesting strong evidence of Ambra1’s role on 
the autophagic pathway. After autophagy induction, Lys63-linked ubiquitin of ULK1 by Ambra1 helps 
the self-association of ULK1. Additionally, this ubiquitination can be prevented by mTORC1-mediated 
phosphorylation of Ambra1, which is an inactive state of Ambra1 proteins (Nazio et al., 2013). This 
mechanism is regarded as a positive-feedback loop, in which Ambra1 functions to ‘fine-tune’ the 




1.2.2.2 Role of Ambra1 on mitophagy 
Additionally, interaction between Ambra1 and LC3 was revealed as another evidence of the role of 
Ambra1 in autophagy, especially in mitophagy (selective autophagy of mitochondria) (Strappazzon et 
al., 2015). Under the basal conditions, Ambra1 binds to mitochondrial Bcl-2 (mBcl-2) on the 
mitochondrial membrane (Strappazzon et al., 2011). After the induction of mitophagy, Ambra1 binds to 
the LC3 interacting region (LIR) motif of LC3, the autophagosome adaptor, leading to mitochondrial 
clearance.  
 
1.2.2.3 Role of Ambra1 on apoptosis 
A functional deficiency of Ambra1 might cause cellular apoptosis during the embryonic development 
(Maria Fimia et al., 2007). When tested, reduction in Ambra1 expression lead to an increased 
susceptibility to different apoptotic stimuli (Pagliarini et al., 2012). The cells become more resistant to 
apoptosis, in the presence of caspase-resistant form of Ambra1, compared than wild-type Ambra1, 
indicating a cellular pro-survival effect of Ambra1. Due to the interaction between Ambra1 and mBcl-2, 
anti-apoptotic factor, a crosstalk between autophagy and apoptosis via Ambra1 has been proposed 
(Cianfanelli et al., 2015b). 
1.2.2.4 Role of Ambra1 on cell proliferation 
Cell proliferation during embryonic development was increased in Ambra1 functional mutants (Maria 
Fimia et al., 2007). Recently, Ambra1 was reported as an effector of mTORC1 signaling. mTORC1 
inhibition activates Ambra1 function in autophagy and down-regulates cell proliferation by anti-
proliferative effect of Ambra1 (Cianfanelli et al., 2015b; Nazio et al., 2013). The direct binding of PXP 
motif of Ambra1 to the serine/threonine-protein phosphatase 2A (PP2A) has been found to 
dephosphorylate c-Myc, leading to its degradation. Mutation in the PxPxxxR (PXP) motifs of Ambra1 
had no effect on the autophagic pathway indicating these two functions may depend on different 
regions of Ambra1 (Cianfanelli et al., 2014). Moreover, in the sub-ventricular zone (SVZ) of the adult 
brain, Ambra1 remains highly expressed promoting the survival of neural precursor cells by controlling 




1.2.3 Ambra1+/- mice – Genetic mouse model of autism spectrum disorder 
A number of human genetic studies have connected AMBRA1 gene mutations with psychiatric 
disorders, especially schizophrenia. Schizophrenia is a group of psychotic disorders characterized by 
severely impaired thinking, emotions, and behaviors. A genome-wide association study (GWAS) 
demonstrated an association between schizophrenia and genetic variation on the human chromosome 
which contains the AMBRA1 gene (Rietschel et al., 2012). Another genetic study showed an 
association between AMBRA1 and various aspects of impulsivity (Heinrich et al., 2013) 
 
 
Figure 2. Composition of the autism severity score and autism composite score in Ambra1+/- 
and Ambra1+/+ mice of both males and females 
The upper row (A, C) shows results for females, the lower row (B, D) for male mice. A, B: Z-
standardized autism-relevant readouts from mouse behavior experiments which represent three main 
domains in ASD; C, D: Autism composite score calculated by averaging z-standardized score from 
Figure A and C. The comparison of mutant and control groups was analyzed by Mann-Whitney U-tests. 
Mean±SEM presented; n numbers of each group are presented in the figures. Adapted from Frontiers 
in Behavioral Neuroscience (Dere et al., 2014). 
 
Recently, we performed a comprehensive behavioral analysis of Ambra1+/- mice and reported autism-




stereotypies or repetitive behaviors and impaired cognitive flexibility (Dere et al., 2014). Fig 2. A and B 
show z-standardized scores of behavioral readouts which cover all three main diagnostic domains 
(communication, social interaction and stereotypies/repetitive behaviors). Here, the scores of 
Ambra1+/- females were higher than control females in most of the parameters, while there was no 
significant difference between the two genotypes in males. Thus, the average of all z-standardized 
scores, reflecting the autism composite score, was profoundly higher in female Ambra1+/- mice 
compared to control females whereas it was not significantly different in male mice (Fig 2. C and D). 
And this indicates the female-specific autism-like behavior in Ambra1+/- mice. 
 
1.3 Characteristics of neurons; in the prospective of hippocampal 
pyramidal neurons 
1.3.1 The structure of the hippocampus 
The hippocampus has been a major region of the brain for characterization of neurons in different 
contexts, from electrophysiological properties and morphological features to synaptic plasticity as a 
mechanism of information processing and storage in the brain. The hippocampus is composed of the 
dentate gyrus and the Ammon’s horn field which contains four parts of the Cornu Ammonis 1-4 (CA1-
4). 
The hippocampus is composed of simple laminar patterning of a neuronal pathway, called the 
trisynaptic loop, which enables extracellular recording techniques to record synaptic events in vivo or 
in vitro. Fig 3. A and B represent the wiring system of hippocampus as a trisynaptic loop. Sensory 
information of neurons in layer II of the entorhninal cortex conveys excitatory input to the dendrites of 
granule cells via perforant path (PP). Granule cells project to the proximal apical dendrite of CA3 
pyramidal cells via the mossy fiber pathway. Axons of CA3 pyramidal neurons project to ipsilateral 
CA1 pyramidal neurons through Schaffer collaterals and to contralateral CA3 and CA1 pyramidal cells 
through commissural connections. CA3 pyramidal neurons also receive direct input from layer II cells 
of the entorhinal cortex. Layer III cells of the entorhinal cortex innervate the distal apical dendrites of 






Figure 3. The illustration of hippocampal trisynaptic loop and hippocampal CA1 pyramidal 
neuron 
A, B: Illustrations of hippocampal neural network. The traditional trisynaptic pathway (entorhinal cortex 
(EC)–dentate gyrus–CA3–CA1–EC) is shown by solid arrow. The axons of layer II neurons in the 
entorhinal cortex project to the dentate gyrus through the perforant pathway (PP), including the lateral 
perforant pathway (LPP) and medial perforant pathway (MPP). The dentate gyrus sends projections to 
the pyramidal cells in CA3 through mossy fibers. CA3 pyramidal neurons relay the information to CA1 
pyramidal neurons through Schaffer collaterals. CA1 pyramidal neurons send back-projections into 
deep-layer neurons of the EC. CA3 also receives direct projections from EC layer II neurons through 
the PP. CA1 receives direct input from EC layer III neurons through the temporoammonic pathway 
(TA). The dentate granule cells also project to the mossy cells in the hilus and hilar interneurons, 
which send excitatory and inhibitory projections, respectively, back to the granule cells. Adapted with 
permission from Nature Publishing Group with license number #3912761270009 (Deng et al., 2010) C: 
The structures of pyramidal neuron in CA1 of the hippocampus. It is consisted of short basal and one 
long apical dendrites and an apical tuft at the end. Adapted with permission from Nature Publishing 
Group with license number # 3912771321428 (Spruston, 2008) 
1.3.2 Hippocampal pyramidal neuron 
Pyramidal neurons are found in several regions of the CNS including the hippocampus have one 
distinct large apical and short basal dendritic trees and the pyramidal shape of their soma, as shown in 
Fig 3. C (Spruston, 2008). The activation of pyramidal neuron is able to excite the interneurons. 
Excitatory inputs onto the pyramidal cells occur on the dendritic spines, whereas the inhibitory inputs 
target the soma, axon or dendritic shaft. Parvalbumin (PV) positive basket cells preferentially form 
synapses onto the soma of the pyramidal cells, whereas somatostatin positive interneurons 
preferentially synapse onto the axon initial segment of pyramidal neurons causing a modularity effect 





1.4 Functional characteristics of neurons 
1.4.1 Synaptic plasticity 
Synaptic plasticity refers to the activity-dependent changes of the strength or efficacy of synaptic 
transmission at preexisting synapses. In other words, neuro-adaptation to a wide range of 
environmental stimuli is a requirement that the synaptic transmission can be either enhanced or 
depressed. This modification can persist from milliseconds to hours or even longer, indicating a role in 
incorporating transient experiences into persistent memory traces and modifying thoughts, feelings 
and behavior. Recently, it has been reported that synaptic plasticity is involved in the early 
development of neuronal circuitry and has been linked to several neuropsychiatric disorders (Citri and 
Malenka, 2008). 
Due to the laminar structure of hippocampus, the technique of extracellular recording acute 
hippocampal slices is widely used for long-term plasticity (LTP) measurements. Traverse hippocampal 
slices with intact Schaffer collateral projections enable extracellular recordings to measure field 
excitatory postsynaptic potentials (fEPSPs) in the apical dendritic part of CA1 in the Stratum radiatum 
upon stimulation of the Schaffer collateral projections.  
1.4.1.1 Short-term synaptic plasticity: Paired-pulse ratio 
Several forms of short-term synaptic plasticity, lasting from milliseconds to several minutes, have been 
observed in synapses of different organisms, ranging from simple invertebrates to mammals (Zucker 
and Regehr, 2002). These short-term adaptations to sensory inputs have been considered to be a 
short-lasting form of memory by inducing transient changes in behavioral states. At the experimental 
level, short-term plasticity can be measured through a paired-pulse ratio (PPR). PPR is upon two 
stimuli within a short-time interval which will lead the response to the second stimuli to be either 
enhanced or depressed compared to the response to the first stimulus. Paired pulse depression is 
observed at short inter-stimulus intervals (ISI<20 msec) and most likely caused by inactivation of 
voltage-dependent sodium and calcium channels or by a transient depletion of the readily-releasable 
pool of vesicles docked at the presynaptic terminal. Paired-pulse facilitation can be detected at longer 




action potential contributes to additional release during the second stimulation, but additional 
mechanisms are likely to be involved such as activation of protein kinases that modulate the activity of 
presynaptic phosphoproteins (Citri and Malenka, 2008). 
1.4.1.2 Long-term synaptic plasticity: Early-phase long term potentiation (E-LTP) 
Among different forms of plasticity, LTP in the CA1 region of the hippocampus has been studied the 
most extensively. It refers to the activity-dependent and long-lasting modifications of synaptic strength 
and is involved in rapid information storage and various forms of long-term memory. 
LTP can be measured in acute hippocampal slices by recording fEPSPs generated upon stimulation of 
presynaptic fibers during a short-duration train of high-frequency electric stimuli typically at 100 Hz for 
1 sec (D V Madison et al., 2003). LTP is characterized by two phases; baseline before the induction of 
LTP and maintenance phase of sustaining potentiation after the induction of LTP (Sacktor, 2008). 
There are two major types of ionotropic glutamate receptors which are important for LTP: α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPARs) and N-methyl-D-aspartate 
(NMDA) receptors (NMDARs). During basal synaptic transmission, glutamate binds to the NMDA and 
AMPARs. AMPARs contains a channel permeable to monovalent cations (Na+ and K+), and activation 
of AMPARs will generate inward current which provides the excitatory post-synaptic response when 
the cell is close to its resting membrane potential. In contrast to AMPARs, the NMDAR channels allow 
Na+ and Ca2+ into the postsynaptic dendritic spines. During basal synaptic transmission, it contributes 
little to the postsynaptic response due to blockage of its channel by extracellular Mg2+ (Citri and 
Malenka, 2008). High frequency stimulation (e.g. 100Hz) of the presynaptic fibers results in a large 
depolarization of the postsynaptic membrane and glutamatergic inputs simultaneously, leading to 
dissociation of Mg2+ from NMDAR channel and calcium influx into the postsynapses (Raymond, 2007).  
1.4.2 Neuronal oscillation 
Neuronal oscillations refer to rhythmic and repetitive fluctuation resulting from a generation of 
temporally coordinated spikes within the neuronal circuits. A single action potential in regular manner 
generates rhythmic activation of postsynaptic neurons, resulting in a periodic fluctuation in the 




amplify the output signal and produce a fluctuating field potential signal, which will be easily measured 
by extracellular recording (Bartos et al., 2007). 
Oscillations can be characterized by their frequency (Hz), peak amplitudes (Power=Amplitude2). 
Based on their frequencies, they can be categorized as delta oscillations (0.5-3 Hz), theta oscillations 
(3-8 Hz), alpha oscillations (8-13 Hz), gamma oscillations (30-90 Hz), and ultrafast oscillations (90-200 
Hz). Oscillatory activities take place in different regions of the brain and are correlated with higher 
brain functions (Mann and Paulsen, 2007; Mathalon et al., 2015). Different forms of neuronal 
oscillations have been extensively studied in human EEG, recorded on the scalp (Buzsáki et al., 2012). 
For example, the theta range is usually detected during an exploratory behavior as well as rapid eye 
movement (REM) sleep. Disruption of gamma oscillations could underlie some psychiatric disorders, 
such as schizophrenia and ASD (Bartos et al., 2007). 
1.4.2.1 Gamma oscillations 
Among different types of neuronal oscillations, gamma oscillations (30-80 Hz) have been extensively 
investigated since they have been involved in cognitive functions, recall of memory, sensory 
processing and memory formation. Gamma oscillations have been studied in different areas of the 
brain; neocortex (Fries et al., 2001; Gray et al., 1989; Murthy and Fetz, 1992; Sirota et al., 2008), 
entorhinal cortex (Chrobak and Buzsáki, 1998), amygdala (Halgren et al., 1977; Popescu et al., 2009), 
hippocampus (Bragin et al., 1995; Buzsáki et al., 1983; Mann et al., 2005), striatum (Berke et al., 
2004), thalamus (Pinault and Descheˆnes, 1992) and other areas. The major explanation about the 
generation of gamma oscillation is the regulation of neuronal network by PV-positive basket cells. 
They are present in the pyramidal cell layer of CA1 and CA3 (Miles et al., 1996) and they have fast 
spiking properties at the similar frequency of gamma oscillations (Jonas et al., 2004).  
Gamma oscillations in the hippocampus have been studied via extracellular recording acute brain 
slices upon application of electric stimulation (Whittington et al., 1995) or chemical stimulation such as 
3,5 dihydroxyphenylglycine (DHPG) for metabotropic glutamate receptors (mGluRs), carbachol for 
muscarinic acetylcholine receptors (mAChRs), or kainate for kainate receptors (Fisahn et al., 1998, 
2004; Mann et al., 2005). Application of different chemical stimulants together with different 




induction by kainate receptor or mGluRs can be blocked by bicuculline but not by AMPA receptor 
antagonists, indicating that kainate-induced or DHPG-induced oscillations are mainly dependent on 
inhibition (Fisahn et al., 2004; Whittington et al., 1995). In contrast, induction by Carbachol can be 
blocked by both AMPA receptor antagonist and GABAA receptor antagonist, indicating that these 
oscillations are dependent on both excitatory and inhibitory pathways (Fisahn et al., 1998). 
 
1.5 Aim of the present study 
The aim of the present study was to identify how reduced expression of Ambra1 protein changes the 
characteristic of neurons in Ambra1+/- mice in order to explain the autism-like phenotype only in 
Ambra1+/- female mice. 
Therefore, quantification and localization of protein in the brain was studied. Other symptoms or 
comorbidity of autism, such as brain enlargement or epileptic seizure were also observed in this 
mouse line. Moreover, change of the neuronal network and neuronal morphology in Ambra1+/- mice 
was studied in the hippocampus. 
Overall, this is the first study to investigate the involvement of Ambra1 in the neuronal features 




2 Method & Materials 
2.1 Methods 
2.1.1 Animals 
Ambra1 mutation was made by inactivation of Ambra1 gene which has been described in detail 
previously (Maria Fimia et al., 2007). Ambra1 wild-type (WT, Ambra1+/+) and Ambra1+/- (Het) 
littermates of both genders with a >99% C57BL/6N genetic background were used for in vivo study. 
They were obtained from male Ambra1+/- and female WT C57BL/6N breeding pairs. This investigation 
was carried out in agreement with the guidelines for the welfare of experimental animals issued by the 
Federal Government of Germany and the Max Planck Society. 
2.1.2 Genotyping 
2.1.2.1 Extraction of DNA from tail-tip biopsies 
Genomic DNA for genotyping was extracted from tail tips of 2-3 week-old offsprings or embryos using 
NucleoSpin Tissue kit. The tail tips were lysed by incubation in 180 μl T1 buffer and 25 μl Proteinase K 
for more than 3 hr at 56°C. After application of 200 μl B3 buffer and 210 μl ethanol, the lysate was 
transferred to a column followed by centrifugation at 11,000 rpm for 1 min at room temperature (RT). 
The column was washed by 500 μl BW buffer and 600 μl B5 buffer with centrifugation at 11,000 rpm 
for 1 min at RT between each step. After drying membrane by same centrifugation method as previous, 
the DNA sample was eluted in 100 μl of pre-warmed BE buffer (70°C). 
2.1.2.2 PCR for genotyping 
Ambra1 WT type gene, Ambra1 mutated gene and Y chromosome of offsprings or embryos were 
detected by PCR of genomic DNA. The primers were synthesized in MPI-EM DNA Core Facility for 
this experiment indicated in the material part (Page No. 37). 
Ambra1 mutated gene can be detected using primers #24509/#24510 to yield a 3 kilo basepair (kb) 
product in Ambra1 mutated gene and #5063/#5064 to produce 350 basepair (bp) product of 
Interleukin-2 (IL-2) as internal control with Failsafe enzyme with PreMix D. PCR of Ambra1 WT allele 




GoTaq® G2 Flexi DNA polymerase. For the sex determination of embryo, PCR of Y chromosome was 
performed using #23366/#23367 to detect 270 bp in Y chromosome with GoTaq® G2 Flexi DNA 
polymerase. All the PCR cycle information is summarized in Table 1. Final PCR products were run on 




Ambra1 mutated allele 
 
94°C 3 min 
 
94°C 30 sec 
x 40 57°C 2 min 30 sec 
72°C 5 min 
72°C 5 min  
Ambra1 wild type allele  
95°C 5 min  
95°C 30 sec 
x 35 57°C 45 sec 
72°C 1 min 45 sec 




94°C 1 min  
94°C 1 min 
x 33 63°C 30 sec 
72°C 30 sec 
72°C 7 min 
  
Table 1. Cycle information of PCR for genotyping 
Cycle information of PCR for the detection of Ambra1 mutated and Ambra1 WT genes and Y 
chromosome is shown in this table. 
2.1.3 Behavior experiments 
2.1.3.1 Observation of neonatal development 
Females were individually housed approximately 2 weeks after pairing and observed twice a week for 
pregnancy and delivery. The day of delivery can be regarded as postnatal day (P) 0 for that litter. The 
litter was not disturbed in their home cage with their mothers until 3 days old when the paws of pups 




Observation of neonatal development was carried out by a trained observer, who is blinded to the 
genotype and sex. The size of litters was restricted to 6-10 pups per litter. The battery of tests 
consisted of a daily assessment of physical and neurodevelopmental as well as neuromotor 
coordination throughout the neonatal period and each readout has different time window of 
observation and performed as described earlier (Ju et al., 2014). Neonatal assessments include (i) 
maturation measures targeting physical development, (ii) neurodevelopmental measures targeting the 
development of neurological reflexes, and (iii) the development of neuromotor coordination.  
2.1.3.1.1 Maturation measures targeting physical development 
Body weight was measured daily and the day of opening both eyes and ears was checked. 
2.1.3.1.2 Neurodevelopmental Measures targeting development of neurological reflexes 
Placing response: Pups were gently grasped around trunk and suspended in the air to make none of 
the paws on ground. A thin metal bar was placed on the top of forepaw and the day when the pups 
raised both fore-paw for two consecutive days was measured. It starts from P4 and was performed 
one trial per day. 
Surface righting reflex: Pups were placed with their back on ground and then released. The time 
needed for pups to right themselves was measured. It was performed twice a day, starting from P4 
until the measured time was within 2 sec in both trials for two consecutive days. 
Cliff avoidance: Forepaws of pups were placed at the edge of cliff and observe the retraction reflex 
(cliff avoidance reflex) within 10 sec by one trail from P6 until they showed the reflex within 10 sec for 
two consecutive days. Both eyes should be closed. 
Negative geotaxis reflex: Pups were placed on an inclined plane (30° angle) with its head facing 
downwards and the time needed for pups to change its orientation in order to face up the incline 
(proper response) was measured. Criterion was reached when the proper response appeared before 





Tactile startle: A puff of air (e.g. experimenter’s breath) was gently applied to the pups, starting on P10. 
The criteria were reached when the proper response (jumping or running) was observed on 3 
consecutive days. 
Ear twitch: The fine filament pulled out from cotton tip was gently brushed on the tip of the ear for 3 
times. The criteria can be reached when the pups showed the ear twitch which is flattening the ear 
against the side of head for 3 consecutive days. 
Air righting reflex: This experiment starts from P10. The pup was held upside down holding both side 
of the head and the hind quarters approximately 10 cm above a cage. The pup was released and 
whether the pup was able to turn right to position upon landing by one trial for 3 consecutive days. 
2.1.3.1.3 Neuromotor Coordination Measures 
Open field traversal: The pup was placed in the center of 13 cm circle and the time needed to escape 
from the circle was recorded, starting from P10. This performance was terminated when the pup still 
stayed within the circle after 30 sec. The criteria were reached when the measured time was less than 
30 sec for two consecutive days. 
Wire suspension: The animals were forced to grip a 3 mm wire starting from P10 onward until the pups 
were able to hang on the wire for 30 sec. The criteria were reached when the pup was able to hold the 
wire for 30 sec for two consecutive days. 
2.1.3.2 Ultrasound vocalizations 
Ultrasonic vocalizations (USVs) of pups were recorded between P8-9 by inducing the vocalization 
after the isolation from their mothers and nest (isolation test) in collaboration with Dr. Kurt 
Hammerschmidt in DPZ, Göttingen (Ju et al., 2014).  
Pups were randomly selected and placed in a soundproofed custom-made plastic box (diameter 13.5 
cm). An ultrasound microphone (UltraSoundGate CM16) in the lid of the box, 12 cm above the bottom, 
was connected to a preamplifier (UltraSoundGate 116) coupled to a notebook computer. The total 
number of calls and calling duration were measured during an observation period of 3 min. USVs were 




following selection criteria: Possible changes per step=4 (4687 Hz), minimal continuity=5 and 8 msec 
for neonatal and juvenile recording, possible frequency range=35 – 150 kHz.  
2.1.3.3 Pentylenetetrazol (PTZ)-Induced Seizure 
The protocol was performed as described before in a publication where I was co-author (Wojcik et al., 
2013). Seizure activity was induced in awake mouse by a single intraperitoneal (i.p) injection of 50 mg 
of Pentylenetetrazol (PTZ), per 1 kg of body weight. After injection, the mouse was observed closely 
for 30 min in a small and clear home cage. This experiment was carried out in 23-25 day-, 12-13 
week- and 13 month-old Ambra1 WT and Het mice in both sexes. 
Four phases of behavioral response to PTZ injection were defined as follows: 1) Hypoactivity; 
Decrease in mobility until the animal take a rest in a crouched or prone position by contacting the 
abdomen at the bottom; 2) Partial clonus (PC); Clonic seizure activity in face, head, and forelimbs; 3) 
Generalized clonus (GC); Sudden loss of upright posture, whole body clonus including all four limbs 
and tail, rearing and autonomic signs; and 4) Tonic-Clonic (TC) (maximal) seizure; Generalized 
seizure with tonic hind-limb extension followed by death. Latencies to PC, GC and TC seizures were 
used to produce from each mouse a seizure score as a quantitative trait measure for mapping by the 
following equation: 
 
Since GC is a more significant event than PC and TC is regarded as the strongest phenotype, the 
weighting factors (0.2, 0.3, and 0.5) were used in this equation as a measure of the progressive nature 
of the PTZ-induced seizure phenotype into the rate of severity (Bodda et al., 2013; Ferraro et al., 




2.1.4 Biochemical analyses  
2.1.4.1 Real-time quantitative reverse transcription-PCR (RT-qPCR) 
2.1.4.1.1 Extraction of total RNA 
Isolation of total RNA was carried out from cortex tissue of 60-week old mice with miRNeasy Mini Kit 
according to manufacturer’s protocol. For details, cortex tissues were homogenized with homogenizer 
in 700 μl QIAzol followed by passing through a syringe with 27G needle for three times. The lysates 
were incubated for 5 min at RT and 140 μl of chloroform were applied. After centrifugation at 12,000 
rpm at 4°C for 15 min, the aqueous phase was collected and mixed with 1.5 times of 100% ethanol. 
This mixture was applied on the miRNeasy Mini column and flew through by centrifugation at 8,000 
rpm for 15 sec at RT. The column was washed once by 700 μl RWT buffer and twice by 500 μl RPE 
buffer together with same centrifugation as previous in each step. After centrifugation at 14,500 rpm 
for 1 min, the total RNA was collected in 50 μl RNase free water at 8,000 rpm for 1 min at RT. The 
RNA concentration was measured after dilution of sample into 1:25 in RNase free water by 
GeneQuant II spectrometry at 260 nm. 
2.1.4.1.2 Synthesis of cDNA  
Reverse transcription of purified RNA was performed using the SuperScript III Reverse Transcriptase, 
following manufacturer’s manual. For detail, each reaction, 1 μg of total RNA together with 120 pmol 
N9 random primers and 0.6 pmol oligo(dT)-mix in a volume 12 μl was incubated at 70°C for 2 min 
followed by adding 8 μl of master mix including 1 μl 200 U/μl SuperScript III, 4 μl 5x first strand buffer, 
2 μl 0.1 M DTT and 1 μl 10 mM dNTPs. The mixtures went through the cycle consisting of 10 min at 
25°C, 45 min at 50°C and 45 min at 55°C. Afterwards, the samples were diluted into 1:10 with ultra-
pure water and stored at -20°C. 
2.1.4.1.3 qPCR 
For qPCR, 4 µl cDNA, 6 µl of Power SYBR Green PCR Master Mix (Life Technologies) and 5 pmol of 
primers in a total volume of 10 μl was pipetted into 384 well-plates by the Epmotion robot 7075. The 
primers were synthesized from MPIEM DNA Core Facility for this experiment and are listed in the 




the difference between Ambra1 WT and mutant allele is coming from and #9146/#9147 for β-actin. 
The qPCR reactions were held on LightCycler 480 System with 3 technical replicates under the 
following cycle: Initiation; 50°C, 2 min / Denaturation; 95°C, 2 min / 45 cycles; 95°C, 15 sec & 60°C, 1 
min. The cycle threshold method (LightCycler® 480 Software release 1.5.0 SP3) was used for 
calculation of relative expression levels of Ambra1 normalized to β-actin. 
2.1.4.2 Protein extraction and Western blot 
2.1.4.2.1 Extraction of protein 
Homogenization of total protein was performed from cortex tissue of 60-week old mice in RIPA-lysis 
buffer with Halt Protease Inhibitor Single-Use Cocktail using homogenizer. The supernatant was used 
for protein analysis after centrifugation at 12,000 rpm for 45 min at 4°C. 
2.1.4.2.2 Measurement of protein concentration 
The protein concentration was measured by Lowry assay. Briefly, the protein samples were diluted in 
a total volume of 200 μl. In parallel, BSA solution in 1 mg/ml was diluted for standard curve (0, 2.5, 5, 
7.5, 10, 12.5, 15, 20 μg/200 μl). After adding 1 ml of copper solution to each sample, these mixtures 
were vortexed and incubated for 15 min at RT. 100 μl of Folin-Ciocalteu reagent were added followed 
by vortex and incubation for 45 min at RT. The absorbance at 595 nm from triplicates of 200 μl/well in 
96 well-plate was measured and the concentration of protein sample was calculated from the standard 
curve. 
2.1.4.2.3 Western Blots 
Protein lysates were denatured by incubation at 95°C for 5 min in a Laemmli buffer and stored at -
80°C. 50 µg of protein was loaded on two-layered polyacrylamide gel consisting the upper stacking gel 
and lower 8% separating gel (Bio-Rad Mini-PROTEAN® Electrophoresis) and electrophoresis was 
performed by being soaked in running buffer under a constant voltage of 80 V in upper stacking gel 
and 120 V in lower separating gel. The PageRuller or PageRuler Plus Prestained Protein Ladders 
were used as protein markers. Separated proteins from SDS-PAGE were transferred onto 
nitrocellulose membrane inside a blocking tank unit with transfer buffer under a constant current of 80 




according to manufacturer’s protocol in order to stain proteins. After destaining and washing 
membranes were blocked in a blocking buffer which is 5% non-fat milk in Tris-buffered saline-Tween 
(TBST; 50 mM Tris, 150 mM NaCl, 0.5% Tween 20, pH 7.4) for 1h at RT. This blocking buffer was 
used for dilution of primary and secondary antibodies. The membranes were incubated with primary 
antibodies including anti-Ambra1 and anti-actin at 4°C overnight followed by incubation with 
horseradish peroxidase conjugated secondary antibody diluted in 5% non-fat milk in TBST for 1 hr at 
RT with washing three times for 15 min in TBST between each step. Antibody information is described 
in the material section (Page No. 37). The signal on the membrane was exposed to Amersham 
Hyperfilm enhanced chemiluminescent (ECL) by Immobilion Western chemiluminescent horseradish 
peroxidase (HRP) substrate and measured by Image J. Ambra1 bands were all normalized to their 
respective actin signals and were expressed in % of average value in male WT. In order to compare 
difference between WT and Het in male and female, all the values were normalized by the average 
WT value in each sex as 100% and this normalized Het value was subtracted from 100%.  
2.1.5 Magnetic resonance imaging (MRI) 
Female and male Ambra1 WT and Het mice were investigated in juvenile period (P23-25, Ambra1 WT; 
n=15/10, Ambra1 Het; n = 15/9 (Female/Male)). For MRI, animals were initially anesthetized using a 
chamber pervaded with 5% isoflurane. Subsequently, the mice were intubated, artificially ventilated 
and maintained under anesthesia with 1.75% isoflurane in ambient air. The animals were then placed 
in a prone position on a purpose-build palate holder. Respiratory movement and rectal temperature 
were monitored. A heated water bed was used to maintain the rectal temperature at 36±1ºC. MRI was 
performed at 7 and 9.4 T. Radiofrequency excitation and signal reception were accomplished with the 
use of a birdcage resonator (inner diameter, 72 mm) and a four-channel phased-array surface coil, 
respectively. T2-weighted MRI data were acquired with a three-dimensional fast spin-echo MRI 
sequence (repetition time TR = 3.5 sec, effective echo time TEeff = 55 msec, 12 differently phase-
encoded echoes, 56 min measuring time) at an isotropic spatial resolution of 100 µm.  
2.1.5.1 MRI Volumetry 
Surface reconstructions and volume-rendered visualizations of the brain were computed from T2-




selected brain structures were generated by importing DICOM images into AMIRA which offers 3D 
reconstruction and visualization tools. Structures of interest such as the whole brain, cerebellum, 
olfactory bulb, hippocampus and ventricles (the lateral and third ventricles) were manually as well as 
semi-automatically labeled with the use of the program’s segmentation editor. All brain areas were 
segmented on three-dimensional label fields (80 horizontal, 192 coronal, and 144 sagittal slices). All 
objects could be visualized independently, rotated in space, and overlaid onto anatomical images, 
while maintaining spatial relationships. The experimenter performing the analyses was not aware of 
the genotype of the mice. 
2.1.6 Histological and immunohistochemical analyses 
2.1.6.1 Perfusion 
Mice were anesthetized by i.p. injection with 0.276 mg Avertin per g of body weight and perfused 
transcardially with Ringer solution followed by 4% paraformaldehyde (PFA) in PBS. Brains were taken 
out and post-fixed at 4°C in 4% PFA in PBS for 2 hr for X-galactosidase (X-gal) histochemical staining 
and for overnight followed by cryo-protectant step until sinking down in 30% sucrose solution in PBS 
and cryopreserved in liquid nitrogen for immunohistochemistry. 
2.1.6.2 X-galactosidase (X-gal) staining 
X-gal histochemical staining was performed in 9 week-old Ambra1 WT and Het male mice. The 50 μm 
coronal brain sections were cut using Leica VT1000S vibrotome and incubated for overnight in the 
dark at 37°C in X-gal solution which is described in the material part (Page No. 36), rinsed in PBS (3 
times), and mounted with Aqua-Poly/mount medium. Digital images were obtained using Axiophot 
microscope. 
2.1.6.3 Immunohistochemistry (Colocalization of β-Gal with different cellular markers & 
counting CTIP2+, GAD67+ and PV+ cells) 
Colocalization of β-Gal with different cellular markers (NeuN, Olig2, GFAP and IBA-1) and counting 
CTIP2+, GAD67+ and PV+ cells were carried out in 23-day old Ambra1 WT and Het female mice. 




The sections including hippocampal regions were blocked with 10% normal horse serum (NHS) and 
0.2% Triton X-100 in PBS for 1 hr at RT. 5% NHS and 0.2% Triton X-100 in PBS was also used for the 
primary and secondary antibody dilution. The information of primary and secondary antibodies that 
were used in this study is indicated in the material section (Page No. 37-38). Incubation of the primary 
antibodies was carried out at 4°C for 1-3 nights, followed by incubation of secondary antibodies for 2 
hr and DAPI for 5 min at RT with dilution factor as 1:500 for primary antibodies and 1:1000 for 
secondary antibodies. Washing using PBS for 5 min x 3 times was performed between every step. 
Lastly, sections were mounted using Aqua-Poly/mount. 
2.1.6.4 Image acquisition 
Confocal laser scanning microscopy (Leica TCS SP5) was used to scan for co-localization of β-Gal 
with different cellular markers and counting CTIP2+ and GAD67+ cells in anatomically matched 
sections using 0.5 μm intervals and 20x glycerol objective lens. Images of PV+ cells in the 
hippocampal pyramidal layer (CA1+CA2+CA3) were obtained using a 20x objective in epifluorescence 
microscopy (Leica DMI6000). 
For counting CTIP2+, GAD67+ and PV+ cells, every 10th section obtained from the dorsal part of 
hippocampus (Bregma –1.34 to –2.54 mm posterior) was analyzed bilaterally in each animal (3 
sections per animal). Cell density was obtained by dividing the number of CTIP2+ and GAD67+ in 
hippocampal CA1 pyramidal layer and PV+ cells in hippocampal pyramidal layer per animal by the 
total volume of hippocampal region in mm3. Stacks were further processed by Image J. The final 
quantification of CTIP2+, GAD67+ and PV+ cells was done using Imaris 7.5.1.  
2.1.7 Electrophysiological analysis of hippocampal pyramidal neurons 
2.1.7.1 Synaptic plasticity 
2.1.7.1.1 Preparation of acute hippocampal slice 
3 and 4 week-old Ambra1 WT and Het mice in male and female were used for input-output curve, 
paired-pulse ratio (PPR) and early phase-long term potentiation (E-LTP). The mice were anesthetized 
with Isofluorane and decapitated by cervical dislocation and skull was open. The whole brain was 




The hippocampi were isolated carefully and cut in 300 µm using a McILWAIN tissue chopper. These 
transverse hippocampal slices were immediately transferred and recovered in a chamber filled with 
carbogen (95% oxygen and 5% carbon dioxide)-supplied artificial cerebrospinal fluid (ACSF) at 37ºC 
(3 week-old animal: for 1 hr, 4 week-old animal: for 1 hr 40 min). After the recovery, the slices were 
kept at RT.  
For the measurement, the slice was placed on a recording chamber with carbogen-supplied ACSF and 
maintained at 30ºC. The recording electrode (2-3 MΩ) was pulled from thin-walled borosilicate glass 
capillaries using a pipette puller, filled with ACSF. To evoke fEPSPs, electric stimulations on the 
Stratum radiatum at CA3/CA1 junction for the activation of Schaffer collaterals were applied using a 
concentric metal bipolar electrode with a 100 µs duration time. The recording pipet was positioned in 
the Stratum radiatum of the CA1 area and the recordings were performed using a Multiclamp 700B 
amplifier and a Digidata 1440A. For the analysis, the data were analyzed using AxographX.  
 
 
Figure 4. Illustration of extracellular recording of fEPSP at CA1 Straitum radiatum by 
stimulation of Schaffer collateral  
A: Illustration of positioning stimulating and recording electrode for extracellular recording of CA1 LTP; 
Adapted by permission from Nature Publishing Group with license number #3912761270009 (Deng et 
al., 2010). B: An exemplar trace of evoked fEPSP in CA1 Stratum radiatum, consisting of a fiber volley 
caused by the inward current of the action potential and fEPSP (Bortolotto et al., 2011) C: Enlarged 
picture of initial part of fEPSP. Slope of fEPSP was depicted in red color. 
2.1.7.1.2 Input-Output curve 
For input-output relationship, fEPSPs were evoked with different stimuli at 1/30 Hz and an average of 
two consecutive responses was used for analysis. Slopes of fEPSPs taken at the initial linear parts of 




volley (FV) measured at the negative peaks of FV were used at the x-axis of the curve. Linear 
regression was performed on the individual slices to calculate the linear fit slope as the slope of the 
linear input-output relationship. 
2.1.7.1.3  Paired pulse ratio (PPR) 
The stimulation intensity was determined as 40-50% of the maximal fEPSP slope. Pairs of stimuli were 
given with various interstimulus intervals (ISI) between 10-1000 msec (10, 25, 50, 100, 200, 500, and 
1000 msec). The ratio of the second fEPSP slope to the first fEPSP slope was analyzed. Average of 
two or three repetitive trials were used for each point per slice. 
2.1.7.1.4  Early phase long-term potentiation (E-LTP) 
The stimulation strength was adjusted to yield 40-50% of the maximal fEPSP slope. The fEPSP was 
continuously monitored every 30 second. After measurement of a stable baseline at least for 20 min, 
E-LTP was induced by a single train of high frequency stimulation (HFS) consisted of 100 pulses at 
100 Hz. 1 min after LTP induction, fEPSP was measured for 40 min. If fEPSP after LTP induction was 
lower than baseline level, the recording was discarded. 
2.1.7.2 Gamma oscillation in CA3 pyramidal layer of hippocampus 
2.1.7.2.1  Preparation of acute brain slices 
3 and 4 week-old mice were anesthetized with Isofluorane and decapitated. Skull was open and each 
hemisphere was cut 5° tilted from the midline. The cutting side was placed on the Leica VT1200S 
vibrotome inside a cold slicing solution at 4°C with application of carbogen gas. Tilted sagittal sections 
in 300 µm thickness were obtained using a vibratome. During the cutting procedure, the tissue was 
immersed in carbogen-supplied cold slicing solution. The sections were transferred to a chamber 
carbogen-supplied ACSF at 37°C for 20 min due to recovery. After then, the sections in a chamber 
with ACSF saturated with carbogen gas were kept at RT. 
2.1.7.2.2  Gamma oscillations under interface conditions 
Network activity was evaluated by recording extracellular field potentials. Hippocampal slices were 




33°C supplied by carbogen gas. The recording electrode (2-3 MΩ) was pulled from thin-walled 
borosilicate glass capillaries using a pipette puller, filled with ACSF and placed in the hippocampal 
pyramidal cell layers of CA3. Extracellular field potentials were recorded with a 700B amplifier and the 
Digidata 1440 A data acquisition system with application of a Bessel filter at 3 kHz and a gain of 100. 
For each slice, field potentials were recorded for 30 min during ACSF application as baseline, followed 
by recording of gamma-oscillation field-potentials during application of 100 nM kainate in ACSF for 30 
min. After recording, the electrode was slightly moved and measured to acquire the maximum power 
of gamma oscillations for 10 more minutes. Data were analyzed using Axograph X software. 
 
 
Figure 5. Illustration of extracellular recording of kainate-induced gamma oscillation at CA3 
Stratum pyramidale  
A: Illustration of positioning recording electrode at the CA3 Stratum pyramidale for recording gamma 
oscillation. Adapted and modified by permission from Nature Publishing Group with license number 
#3912761270009 (Deng et al., 2010). B: Representative trace of baseline and after induction of 
gamma oscillation at CA3 Stratum pyramidale. C: Exemplar power spectrum after subtraction of power 
spectrums of baseline and after induction of gamma oscillation. The peak frequency and average 






The power spectrum was calculated for 10-min epochs (last 10 min of each recording) of field activity 
recorded from baseline and kainate application. The baseline power spectrum was subtracted from the 
power spectrum induced by kainate. Frequency of the maximum peak and average power were 
calculated within the gamma oscillatory frequency range (25 – 45 Hz) from the power spectrum.  
2.1.8 Morphological analysis of hippocampal pyramidal neurons 
2.1.8.1 In utero electroporation (IUE) 
Micropipettes for IUE were prepared from 1.5–1.8 X 100 mm borosilicate glass capillaries (Kimble and 
Chase) using HEKA PIP5 temperature controlled pipette puller. To ensure the appropriate tip diameter, 
the filament was heated to 1000°C, and pulling of glass capillary was controlled manually, allowing for 
slow expansion of heated glass. 
E14.5 mouse embryos were subjected to IUE according to permit number 33.19-42502-04-13/1052 
(Hiroshi Kawabe), and previously published work (dal Maschio et al., 2012; Matsui et al., 2011). 
Ambra1 WT pregnant female mice, crossed with Ambra1 Het males, were deeply anesthetized with 
isolfurane (Ecuphar)/oxygen diffusor (Plexx, HNG6), and placed on warm heating pad (32°C). Before 
surgery, the heart rate or the breathing frequency was noted, and the toe pinch-reflex enabled to 
assess the surgical plane. A layer of Vidisic gel was applied onto each cornea to prevent their damage. 
To ensure post-operative analgesia, 3 mg buprenorphine was administered subcutaneously. 
Abdominal wall was thoroughly washed with 70% ethanol, and 50 mg/mL povidon-iodine. Incision of 
about 2 cm in the abdominal cavity was made to expose entire uterus with embryos, which were 
subsequently moistened with warm PBS supplied with penicillin 2000 U/mL, and 2 mg/mL 
streptomycin. Micropipette with the DNA solution with pFUGW (0.1mg/mL) (Lois et al., 2002) and 
pCX::myrVENUS (0.1mg/mL) (Rhee et al., 2006) for myrVenus construct was carefully injected to the 
lateral ventricle of the embryonic brain, and exhausted by expiratory pressure through a pneumatic 
pump. Those DNA constructs were kindly provided by the authors of cited papers. The forceps-type 
electrode was placed around the embryo head accordingly to the targeted brain region (Kolk et al., 
2011), and electric current was applied with ElectroSquare. For electroporation, 38 V pulses were 
applied six times with 50 msec duration for each pulse with 950 msec intervals. After pulsing, embryo 




carefully placed back to the abdominal cavity, and the body wall was closed with absorbable surgical 
sutures (Safil, Aesculap; 4/0, 28’’; HR17), and the skin with 9 mm Autoclips. The animals were kept on 
the warm pad until back to consciousness. The mouse was monitored post-operatively until deceased. 
2.1.8.2 Immunohistochemistry for dendritic morphology and spine number 
2.1.8.2.1 Perfusion & section preparation 
At P28, Ambra1 WT and Het mice in both sexes went through intracardiac perfusion with PBS and 4% 
PFA in PBS for 15 min. Afterwards, brains were post-fixed in 4% PFA in PBS for overnight, washed 
with PBS thoroughly and subjected to sucrose gradient (15%-30% w/v sucrose in PBS). Coronal brain 
sections in 230 μm thicknesses were collected by the Leica VT1000S vibrotome and stored in PBS 
with 0.01% sodium azide, and kept at 4°C until further processing. 
Imaging of brain coronal cross sections after in utero electroporation was performed at -1.06 mm to -
2.46 mm from Bregma. For immunofluorescence staining, PFA was quenched from brain sections by 
application of 1mg/1mL NaBH4 in PBS for 5 min and sections were thoroughly washed with PBS. The 
brain sections were blocked in blocking solution (5% Normal goat serum and 0.5% Triton-X-100 in 
PBS) for 1 hr at RT followed by 0.2% Tween-20 and 10 μg/mL heparin in PBS for 1.5 hr on the 
purpose of penetration of antibody in the thick brain section. This blocking solution was also used for 
the primary and secondary antibody incubation with dilution factor, 1:1000 (Page No. 37-38). The 
incubation of polyclonal rabbit GFP antibody was carried for 4 days at 4°C with gentle agitation. 
Sections were incubated in Alexa Fluor 488 goat anti-rabbit for overnight at RT with washing for 8 hr 
after incubation of each antibody. The information of antibody and dilution is described in Material part. 
The incubation of DAPI, diluted as 1:10000 in PBS, was followed for 1hr at RT. After washing, sections 
were on slide and coverslip was mounted using Immu-Mount. 
2.1.8.2.2 Image acquisition and analysis 
For dendritic morphology, images were acquired from Leica SP2 confocal microscopes (Leica) with oil 
immersion 20x objectives and 2 optical zoom. Image stacks of pyramidal cells in the middle of CA1 
area were acquired at 1.02 μm intervals and the dendritic morphology was reconstructed and sholl 




automatic tracing and 3D reconstruction of neuron structures from confocal image stacks (Rodriguez 
et al., 2008). It is able to handle morphologic details on the scale of local spine geometry via complex 
tree topology to the multi-neuron networks. 
 
 
Figure 6. Dendritic reconstruction and 3D sholl analysis by NeuronStudio program 
A, B: Representative picture of dendritic reconstruction of CA1 pyramidal neuron in 2D and 3D picture. 




2.1.9 Statistical analysis 
All data were analyzed separately for males and females. Between group-comparisons were made by 
t-test for independent sample. Survival analysis was performed for the data in Fig 16. F. All statistics 
were performed in Prism Graph Pad software. Data presented in the figures and test are expressed as 







30% Acrylamide Merck KGaA, Darmstadt, Germany 
Agarose Life Technologies GmbH, Darmstadt, Germany 
Ammonium persulfate (APS) Sigma-Aldrich, Taufkirchen, Germany 
Aqua-Poly/Mount Polyscience, Philadelphia, USA 
Bromophenol blue Sigma-Aldrich, Taufkirchen, Germany 
BSA 10mg/ml (100x) Neu England Biolabs (NEB), Hitchin, UK 
Buphrenorphine (Temgesic)  
Chloroform Merck KGaA, Darmstadt, Germany 
CuSO4 Merck KGaA, Darmstadt, Germany 
EDTA Sigma-Aldrich, Taufkirchen, Germany 
Ethylene glycol Sigma-Aldrich, Taufkirchen, Germany 
Folin-Ciocalteu reagent Merck KGaA, Darmstadt, Germany 
Formaldehyde Merck KGaA, Darmstadt, Germany 
Glacial acetic acid Merck KGaA, Darmstadt, Germany 
Glycerol Merck KGaA, Darmstadt, Germany 
Glycine Merck KGaA, Darmstadt, Germany 
HDGreen Plus Safe DNA Dye Intas, Göttingen, Germany 
Heparin Sigma-Aldrich, Taufkirchen, Germany 
37% HCl Merck KGaA, Darmstadt, Germany 
Immuno-Mount Thermo Fisher Scientific, Bonn, Germany 
Isopropanol Merck KGaA, Darmstadt, Germany 
Isofurane Actavis Deutschland GmbH & Co. K, München, Germany 
K-Na-tartrate Merck KGaA, Darmstadt, Germany 
β-Mercaptoethanol Sigma-Aldrich, Taufkirchen, Germany 
MgCl2 Sigma-Aldrich, Taufkirchen, Germany 
Na2CO3 Merck KGaA, Darmstadt, Germany 
NaOH Merck KGaA, Darmstadt, Germany 
Normal horse serum Jackson ImmunoResearch Laboratories, Inc. USA 
Nonfat dried milkpowder AppliChem, Darmstadt, Germany 
Pentylenetetrazol (PTZ) Sigma-Aldrich, Taufkirchen, Germany 
Povidon-iodine Vetasept, 
Power SYBR Green Thermo Fisher Scientific, Bonn, Germany 
Pyronin Y Sigma-Aldrich, Taufkirchen, Germany 
Ringer solution B.Braun Melsungen AG, Melsungen, Germany 
Sodium dodecyl sulfate (SDS) Merck KGaA, Darmstadt, Germany 
Sodium tetraborohydride Sigma-Aldrich, Taufkirchen, Germany 




Sucrose Merck KGaA, Darmstadt, Germany 
TEMED SERVA Electrophoresis GmbH, Heidelberg, Germany 
Tribromoethanol Sigma-Aldrich, Taufkirchen, Germany 
Trizma base Sigma-Aldrich, Taufkirchen, Germany 
Tissue-Tek VWR International GmbH, Darmstadt, Germany 
Triton-X-100 Sigma-Aldrich, Taufkirchen, Germany 
Tween-20 Sigma-Aldrich, Taufkirchen, Germany 
Vidisic gel Buasch + Lomb, Rochester, USA 
Ladders 
Product Company 
PageRuler Plus Prestained protein ladders Thermo Fisher Scientific, Bonn, Germany 
1kb DNA ladder Life Technologies GmbH, Darmstadt, Germany 




Failsafe enzyme with PreMix D Epicentre, Madison, USA 
SuperScript III Reverse Transcriptase Life Technologies, Darmstadt, Germany 
Power SYBR Green PCR Master Mix  Life Technologies, Darmstadt, Germany 
NucleoSpin Tissue Kit MACHERY-NAGEL GmbH & Co. KG, Düren, Germany 
Immobilion Western chemiluminescent HRP 
substrate 
Merck Millipore, Germany 
GoTaq® G2 Flexi DNA polymerase Promega, Mannheim, Germany 
miRNeasy Mini Kit Qiagen, Hilden, Germany 
MemCode Reversible Protein Kit Thermo Scientific, Darmstadt, Germany 
 
2.2.2 Equipment 
Vibrotome or Cryostat Company 
Leica VT 1000S Vibrotome Leica Biosystems, Wetzlar, Germany 
Leica VT 1200S Vibrotome Leica Biosystems, Wetzlar, Germany 
Leica CM1950 Cryostat Leica Biosystems, Wetzlar, Germany 
  
Microscopy Company 
Axiophot microscope Carls Zeiss Microscopy GmbH, Göttingen, Germany 
Leica TCS SP5 confocal microscopy Leica Biosystems, Wetzlar, Germany 
Leica TCS SP2 confocal microscopy Leica Biosystems, Wetzlar, Germany 






7T MRI  Bruker Biospin MRI GmbH, Ettlingen, Germany 
9.5T MRI Bruker Biospin MRI GmbH, Ettlingen, Germany 
Axon Digidata 1440A Molecular devices, LLC., Sunnyvale, USA 
Axon MultiClamp 700B amplifier Molecular devices, LLC., Sunnyvale, USA 
BioRad Mini Trans-Blot Cell system Bio-Rad, München, Germany 
Bio-Rad Mini-PROTEAN Electrophoresis  Bio-Rad, München, Germany 
Birdcage resonator (inner diameter, 72mm) Bruker Biospin MRI GmbH, Ettlingen, Germany 
Concentric bipolar electrode FHC, Bowdoin, USA 
Digidata 1440A Molecular devices, LLC., Sunnyvale, USA 
EpMotion robot 5075 Eppendorf AG, Hamburg, Germany 
Four channel phased array surface coil Bruker Biospin MRI GmbH, Ettlingen, Germany 
GeneQuant II Spectrometry Pharmacia Biotech, Piscataway, USA 
HEKA PIP temperature-controlled pipette puller HEKA, Lambrecht/Pfalz, Germany 
HERA-cell240 incubator Thermo Fisher Scientific, Bonn, Germany 
Heraeus Biofuge haemo Thermo Fisher Scientific, Bonn, Germany 
Heraeus Megafuge 16R Thermo Fisher Scientific, Bonn, Germany 
Homogenizer KINEMATICA AG, Luzern, Switzerland 
Interface recording chamber (BSC-BU Base Unit with 
BSC-HT Haas Top) 
Harvard apparatus, Freiburg, Germany 
Light Cycler 480  Roche, Mannheim, Germany 
McILWAIN tissue chopper Molecular devices, LLC., Sunnyvale, USA 
Mini-peristaltic pump HARVARD apparatus, Holliston, USA 
Multiclamp 700B amplifier Molecular devices, LLC., Sunnyvale, USA 
Pipette puller P-80/PC Sutter Instrument Co., Novato, USA 
Recording chamber 64-1525, HARVARD apparatus, Holliston, USA 
Thermomixer Compact Eppendorf AG, Hamburg, Germany 
UltraSoundGate 116 Avisoft Bioacoustics, Glienicke, Germany 




AMIRA Bisage Imaging, Berlin, Germany 
Avisoft-SASLab 5.2 Avisoft Bioacoustics, Glienicke, Germany 
AxographX Axograph, Berkeley, USA 
Axon instruments Digitizer 1322A (and 
pClamp9.2) 
Molecular Devices, Sunnyvale, USA 
Graphpad Prism 4 GraphPad Software Inc., La Jolla, USA 
Image J Free open source software 
LightCycler 480 software 1.5.0 SP3 Roche, Mannheim. Germany 
NeuronStudio CNIC, Mount Sainai School of Medicine, Newyork, USA 








1.5-1.8 x 10mm borosilicate glass capillaries Kimble and Chase 
Amersham Hyperfilm ECL GE Healthcare, buckinghamshire, UK 
Borosilicate glass capilaries GC150TF-10  HARVARD apparatus, Holliston, USA 
Microwell Plate 96 Thermo Fisher Scientific, Roskilde, Denmark 
Millex Syringe Filter Unit, 0.22μm Merck KGaA, Darmstadt, Germany 
Multiwell plate 384 Roche Diagnostics, Mannheim, Germany 
Nitrocellulose membrane GE Healthcare, buckinghamshire, UK 
SuperFrost ultra plus slide Menzel GmbH, Braunschweig, Germany 
 
2.2.5 Buffers and solutions 
1x TAE 
4.84g Tris base 
1.142ml glacial acetic acid 
2ml 0.5M EDTA, 
Fill ultra-pure water upto 1l, pH8.0 
 
Fresh Copper solution 
20ml 2% Na2CO3 (10g Na2CO3 in 500ml 0.1M NaOH) 
0.2ml 2% K-Na-tartrat (10g K-Na-tartrat in 500ml untra-pure water)  





1.0% Triton X-100 
0.5% sodium deoxycholate 
0.1% SDS, pH 7.4 
 
4x Laemmli buffer 




4mg Pyronin Y 












Ethylene glycol cryoprotectant solution 
498ml Glycerol (85%) 
588ml Ethylene glycol 
912ml 1x PBS 
 
8% lower gel 
10ml 30% acrylamide 
0.59g Tris base 
390μl 10% SDS 
13.13ml ultra-pure water 




1.3ml 30% acrylamide 
0.151g Tris base 
100μl 10% SDS 
6.1ml H2O 
50μl 10% APS 
10μl TEMED 
 
1x Running buffer 
3g Tris base 
18.78g Glycine 
1g SDS 
Fill ultra-pure water upto 1l 
 
1x Transfer buffer 
2.42g Tris base 
11.64g Glycine 
Fill ultra-pure water upto 1l 
 
1x TBS 
50mM Tris base 
150mM NaCl, pH7.4 
 
1x TBST 












1.2mg/mL 5-bromo-2-chloro-3-indoyl-b-D-galactopyranoside in PBS 
 
Slicing solution 
230 mM Sucrose 
26 mM NaHCO3 
2 mM KCl 
1 mM KH2OP4 




10 mM Glucose 
0.5 mM CaCl2 
 
ACSF  
120 mM NaCl 
26 mM NaHCO3 
1 mM KH2PO4 
2 mM KCl 
2 mM MgCl2x6H2O 
10 mM Glucose 
2 mM CaCl2 
320 mOsmol/l, pH7.3 
2.2.6 Primers 
The primers were synthesized in MPI-EM DNA Core Facility for this experiment and mentioned in the 
method part. 
Primer # Detection of gene Sequences 
Genotyping 
  
24508 Ambra1 wild type allele 5’-AAC TGA ACC TGG GTT CTT TGA A -3’ 
24509 Ambra1 wild type & mutated allele 5’-GAA AAG CTC CCC ATC TTT TCT T-3’ 
24510 Ambra1 mutated allele 5’-ATC CCA AGG GCA GTA GAG TTC-3’ 
5063 Interleukin-2 5’-CTA GGC CAC AGA ATT GAA AGA TCT-3’ 
5064 Interleukin-2 5’-GTA GGT GGA AAT TCT AGC ATC ATC C-3’ 
23366 Y chromosome 5’-GGT GTG GTC CCG TGG TGA GAG-3’ 
23367 Y chromosome 5’-GAG GCA ACT GCA GGC TGT AAA ATG-3’ 
cDNA synthesis 
 
4542 N9 5'-NNN NNN NNN-3' 
9578 Oligo (dT)-Mix 5'-TTT TTT TTT TTT TTT TTT TTT TTV N-3' 
qPCR 
  
31502 Ambra1 5´-AGG CTC CAG TGG TGG GAC TTC AC-3´ 
31503 Ambra1 5´-GCC AGG AGC TGA CCA TCT GCA G-3´ 
 9146 ß-actin 5´-CTT CCT CCC TGG AGA AGA GC-3´ 
9147 ß-actin 5´-ATG CCA CAG GA+A1:C17T TCC ATA CC-3´ 
2.2.7 Antibodies 
1°antibody Full name Company Catalog No. Host Poly / Clone 
Ambra1 
Activating molecule in Beclin-1-
regulated autophagy 
Millipore ABC131 rabbit polyclonal 
β-gal β-galactosidase Promega Z3781 mouse monoclonal 
NeuN Neuronal nuclei 
Synaptic 
systems 
266006 chicken polyclonal 
IBA-1 
Ionized calcium binding adaptor 
molecule 1 




Chemicon AB9610 rabbit polyclonal 





2° Antibody Company Catalog Number 
Alexa Fluor 488 donkey anti-mouse IgG Invitrogen A21202 
Alexa Fluor 488 donkey anti-rabbit IgG Life Technologies A-21206 
Alexa Fluor 488 donkey anti-chicken IgG Jackson Immunoresearch 703-546-155 
Alexa Fluor 594 goat anti-mouse IgG Jackson Immunoresearch  115-587-186 
Alexa Fluor 594 donkey anti-rabbit IgG Invitrogen A21207 
Cy3 goat anti-mouse IgG Jackson Immuno Research 115-165-146 
HRP-conjugated anti-rabbit Sigma Aldrich A-0545 
 
GFP Green fluorescent protein MBL 598 rabbit polyclonal 
CTIP2 COUP-TF-interacting protein 2 
Synaptic 
Systems 
325 005 guinea pig polyclonal 
GAD 67 Glutamic Acid Decarboxylase 67 Chemicon MAB5406 mouse monoclonal 







3.1 Assessment of developmental milestones and early ultrasonic 
communication 
 
Figure 7. Neonatal development and pub vocalization in Ambra1+/- versus Ambra1+/+ mice of 
both sexes 
The upper row shows results for female, the lower row for male mice. A, B: Body weight at P4, P14 
and P20; C, D: The day to reach criterion in physical development, neurodevelopment (PR: placing 
response; SRR: surface righting reflex; CA: cliff avoidance; NGR: negative geotaxis reflex; TS: tactile 
startle; ET: ear twitch; ARR: air righting reflex) and neuromotor coordination (OF: open field traversal; 
WS: wire suspension) E-H: Ultrasound vocalization of pups induced by separation from their mother or 
nest on postnatal day 8 or 9. Mean±SEM presented; n numbers of each group are presented in the 
figures. Adapted from Frontiers in Behavioral Neuroscience (Dere et al., 2014). 
 
Given the fact that remarkable autistic phenotypes are evident in Ambra1+/- females from an early 
stage, the observation of neurobehavioral developmental milestones and early ultrasonic 
communication in neonatal mice up to the age of 3-4 weeks is necessary. In order to use Ambra1+/- 
mice as a mouse model of autism, neurological and physical development can be additionally 
characterized for these mice to indicate a phenotypic onset during any developmental time point. 
Physical development including body weight, eye opening and ear opening, the development of 
neurological reflexes and the development of neuro-motor coordination such as open field traversal 




There was a significant reduction in the number of calls induced by separation from mother or nest in 
female Ambra1+/- pups at P8 or P9 compared to control (Number; F_WT: 183.8±19.08, F_Het: 
127.3±21.58, p=0.042; Duration; F_WT: 6.467±0.8219 s, F_Het: 4.654±0.9012 s, p=0.121) (Fig 7. E 
and G), however there was no difference in male mice (Number; M_WT: 180.7±28.77, M_Het: 
220.2±24.75, p>0.05; Duration; F_WT: 6.626±1.265 s, F_Het: 8.500±1.092 s, p>005) (Fig 7. F and H). 
3.2 Ambra1 mRNA and protein expression 
 
Figure 8. Ambra1 mRNA and protein expression level in cortex of male and female Ambra1+/- 
and Ambra1+/+ mice 
A: RT-qPCR; B: Sample Western blot; C: Western blot quantification. D: The relative reduction 
between Ambra1 WT and heterozygous was produced by subtracting the mean value of WT from all 
value of heterozygous in each sex. M=male; F=female; Mean±SEM presented; n numbers of each 
group are shown in the figures. Adapted from Frontiers in Behavioral Neuroscience (Dere et al., 2014). 
 
To understand the sexual dimorphism of autistic behavior, the expression levels of Ambra1 mRNA and 
protein in the cortex of both genotypes and sexes were measured by RT-qPCR and Western Blot. 
Levels of both mRNA (M_WT: 100±5.243, M_Het: 55.94±3.643, p<0.0001; F_WT: 101.5±5.234, 
F_Het: 53.15±2.260, p<0.0001) and protein were significantly lower in Ambra1+/- mice, compared to 
WT controls of both males and females (M_WT: 100±4.085, M_Het: 66.46±7.334, p=0.0025; F_WT: 




levels of Ambra1+/+ were comparable between males and females (p>0.05), Ambra1 protein levels in 
female WT mice was higher compared to male WT (p=0.0082), a drastic reduction upon 
heterozygosity was seen in females (Male: -33.54±7.334, Female: -74.74±4.655, p=0.0008) (Fig 8. D). 
There may be a connection of Ambra1 protein expression and the female-specific autism phenotype. 
3.3 Brain enlargement 
 
Figure 9. Voxel-based volumetry (T2-weighted MRI) of sub-region and whole-part of brain in 
Ambra1 WT and Het mice 
Bar graphs of brain dimension ROI (Whole brain, Cerebellum, Hippocampus, Olfactory bulb and 
Ventricles) in both genotype of A: 3 week-old females (F), B: 3 week-old males (M) and C: 13 month-
old females; Mean±SEM presented; n numbers of each group and p-value by t-test are shown in the 
figures. 
 
Several studies have identified the presence of brain enlargement during childhood in autism 
(Courchesne and Pierce, 2005; Courchesne et al., 2003; Fidler et al., 2007; Hazlett et al., 2011). While 
the neuroanatomical basis of ASD is not yet known, numerous lines of evidence suggest that 
abnormalities in brain volume may be a characteristic of autism. Several MRI studies of very young 




early childhood (Courchesne et al., 2001; Hazlett et al., 2011). Therefore, in collaboration with Prof. 
Jens Frahm in MPI-BPC in Göttingen and Prof. Susann Boretius in Kiel, the brains of Ambra1+/+ and 
Ambra1+/- mice of both sexes in P22-25 and 13 month-old females were imaged by T2-weighted MRI. 
And this allowed for voxel-based volumetry of different region of interest (ROI), including whole brain, 
cerebellum, hippocampus, olfactory bulb and ventricles. 
Fig 9. A depicts an enlargement of the whole brain (F_WT: 424460±4011 voxels, F_Het: 440630±4921 
voxels, p=0.0157), cerebellum (F_WT: 50921±451 voxels, F_Het: 53157±539 voxels, p=0.0034) and 
hippocampus (F_WT: 12540±403 voxels, F_Het: 13897±518 voxels, p=0.0455) in females while there 
was no difference in the size of olfactory bulb (F_WT: 24217±396 voxels, F_Het: 25224±342 voxels, 
p=0.0684) and ventricles (F_WT: 4832±605 voxels, F_Het: 5192±841 voxels, p=0.7731) in 
comparison to WT females. Whole brain (M_WT: 286030±4541 voxels, M_Het: 302960±4573 voxels, 
p=0.0179) and hippocampus (M_WT: 14343±675.2 voxels, M_Het: 17510±550 voxels, p=0.0023) 
were also bigger in male Ambra1+/- mice when compared to control males (Cerebellum; M_WT: 
49797±1211 voxels, M_Het: 51445±952 voxels, p=0.3074; Olfactory bulb; M_WT: 18153±617.3 voxels, 
M_Het: 18834±512.8 voxels, p=0.4138; Ventricles; M_WT: 6538±1180 voxels, M_Het: 6186±1258 
voxels, p=0.8407) as shown in Fig 9. B. This enlargement of whole brain (F_WT: 510111±4209 voxels, 
F_Het: 532625±5871 voxels, p=0.0037), cerebellum (F_WT: 62079±716.0 voxels, F_Het: 
64760±836.2 voxels, p=0.0231) and hippocampus (F_WT: 24952±376.9 voxels, F_Het: 26258±488 
voxels, p=0.0416) in Ambra1+/- females persisted after 12 months (Olfactory bulb; F_WT: 34063±557.7 
voxels, F_Het: 35151±586.5 voxels, p=0.2023; Ventricles; F_WT: 10499±585.8 voxels, F_Het: 
12234±1745 voxels, p=0.2885) (Fig 9. C). 
3.4 Expression of Ambra1 protein in postnatal brain 
Given the fact that brain and sub-brain regions were enlarged in juvenile Ambra1+/- mice as is seen 
with autistic children, the next experiment was to figure out the cellular substrate of this enlargement. 
In order to study this aim, we would like to know in which region of the brain this protein is expressed. 
Since there is no commercially produced Ambra1 antibody for immunofluorescence staining, and β-gal 
activity in a gene-trap line mimics the expression of the tagged endogenous gene (Skarnes et al., 






Figure 10. X-galactosidase staining in coronal brain sections of Ambra1+/+ and Ambra1+/- mice. 
A,C: X-gal staining of same brain region in Ambra1+/+ mice was used as negative control. B,D: 
Coronal brain sections of X-gal staining in Ambra1+/- mice. Scale bar: 100 μm 
 
X-gal staining is a rapid histochemical technique used to detect β-gal, reporter gene expression under 
the promoter of Ambra1. Notably, the lacZ gene encodes the bacterial (E.coli) enzyme β-gal and is 
commonly visualized as a blue intracellular precipitate following an oxidative reaction with substrate 
‘X-gal’. Coronal sections of anterior part with prefrontal cortex and striatum and posterior part with 
hippocampus part of mouse brain in Ambra1+/+ and Ambra1+/- mice were selected for X-gal staining. 
Fig 10. A-D show the expression of β-gal in striatum, prefrontal cortex and hippocampus, especially, in 





Figure 11. Immunofluorescence staining of β-gal and co-localization of β-gal with different 
cellular markers in CA1 region of hippocampus in Ambra1+/- mouse  
The staining of β-gal in the coronal brain sections of A: Ambra1+/+ and B: Ambra1+/- mice, Scale bar: 
100 μm. The co-staining of β-gal with C: NeuN, neuronal marker, D: Olig-2, oligodendrocyte marker, 
E: IBA-1, microglial marker, and F: GFAP, astrocyte marker, in the hippocampal CA1 region of 





On the basis of this data, the expression of β-gal in specific cell types was explored by 
immunofluorescent staining of β-gal together with different cellular markers, such as prototypical 
markers of neurons, microglia, astrocytes and oligodendrocytes, in the brain. First of all, the 
immunofluorescent staining of β-gal was validated by comparing Ambra1+/+ and Ambra1+/- sample (Fig 
11. A and B). This staining protocol was combined with the immunofluorescence staining of NeuN, 
neuronal marker, Olig-2, oligodendrocyte marker, IBA-1, microglia-specific protein, and GFAP, 
astroglial marker. Fig 10. C shows clear co-localization between β-gal and NeuN which is also proved 
by separation of channels. However, Fig 11. D, E and F represent no co-localization of β-gal with Olig-
2, IBA-1 and GFAP indicating that β-gal, which is a marker of Ambra1 expression, shows neuron-
specific expression. 
3.5 Functional study of neuron 
The neuron-specific expression of Ambra1 gives a reason for neuronal characterization in Ambra1+/-. 
Therefore, electrophysiological analysis of neuronal function was performed in the hippocampus 
comparing WT to Ambra1+/-. 
3.5.1 Synaptic plasticity 
Synaptic plasticity is the activity-dependent modification of the strength or efficacy of synaptic 
transmission at preexisting synapses. It is also thought to play key roles in the early development of 
neural circuitry and evidence is accumulating that impairment in synaptic plasticity mechanisms 
contributes to several prominent neuropsychiatric disorders (Citri and Malenka, 2008). 
The hippocampus is well known for the measurement of synaptic plasticity since its laminated 
structure enables extracellular recording by placing stimulating electrodes on the presynaptic fiber 
tracts and recording electrodes near the sites of synaptic termination. The information in the 
hippocampus flows through a “trisynaptic loop” as displayed in Fig 3. A-B. In this study, the Schaffer 
collateral (SC)-CA1 synapses where CA1 neurons are excited by the stimulation of SC axons from 
CA3 pyramidal neuron were analyzed by measuring field excitatory postsynaptic potential (fEPSP) in 
the CA1 Stratum radiatum applying the electric stimulation in the SC afferents (Citri and Malenka, 





3.5.1.1 Input-Output relationship 
 
Figure 12. Input-output curve in Ambra1+/+ and Ambra1+/- mice of both sexes in CA1 Stratum 
radiatum stimulated by Schaffer Collateral 
Graphs of fEPSP slope as a function of FV slope in Ambra1 WT and Het mice of male (M) and female 
(F) in A, B: 21-23 days (M_WT: 9/2, M_Het: 4/1, F_WT: 5/2, F_Het: 10/3, slice number/animal 
number) C, D: 4 weeks old (M_WT: 6/2, M_Het: 6/2, F_WT: 12/3, F_Het: 11/3, slice number/animal 
number); Each data point presents mean±SEM of both x and y values and linear regression was 
shown ; Representative traces of input output curve are presented with each graph. 
 
In order to determine whether Ambra1+/- mice exhibited normal synaptic transmission, the evoked 
fEPSPs were measured by the application of different intensity of stimulus using extracellular field 
recording. The slope of fEPSP was plotted along with its FV slope and a trend line between two is 
depicted in each graph to see the input-output relationship in Fig 12. The input-output relationship was 
not significantly different between Ambra1+/- and control mice, indicating that the loss of Ambra1 does 




3.5.1.2 Paired-pulse ratio (PPR) 
 
Figure 13. Paired pulse ratio (PPR) in Ambra1+/+ and Ambra1+/- mice of both sexes in CA1 
Stratum radiatum stimulated by Schaffer Collateral 
Graphs of ratio between 2nd and 1st fEPSP slope with different interstimulus interval (ISI) (0.01, 0.025, 
0.05, 0.1, 0.2, 0.5, 1 s) of both genotypes in male (M) and female (F) at A, B: 21-23 days (M_WT: 8/3, 
M_Het: 7/2, F_WT: 10/5, F_Het: 11/4, slice number/animal number) and C, D: 4 weeks old (M_WT: 
6/2, M_Het: 6/2, F_WT: 10/3, F_Het: 11/3, slice number/animal number); Mean±SEM presented; 
Representative traces of PPR are shown with each graph. 
 
Short-term synaptic plasticity, lasting milliseconds to several minutes, are thought to play important 
roles in short-term adaptations to sensory inputs, transient changes in behavioral states and short-
lasting forms of memory. PPR, a form of short-term synaptic plasticity, is defined as the ratio of the 
post-synaptic second response to the first response when pair of stimuli is given at the same intensity 
in different time intervals. The maximum PPR in the SC-CA1 synapses generally occurs at short ISIs 




residual calcium in the presynaptic bouton from the first action potential, but additional mechanisms 
are likely to be involved (Citri and Malenka, 2008). 
Fig 13 includes the graphs of PPR versus different ISIs recorded in both sexes and genotypes from 3 
(Fig 13. A, B) and 4 week-old mice (Fig 13. C, D). Both males and females in both ages didn’t show 
any significant difference in PPR between genotypes over a range of the ISIs from 10ms to 1000ms, 
indicating that short-term synaptic plasticity is intact in the heterozygosity of Ambra1. 
3.5.1.3 Early-phase LTP  
In order to examine whether Ambra1 is involved in LTP, SC afferents were stimulated by a single train 
of high frequency stimulation (HFS), consisting of 100 Hz for 1 sec. The slopes of fEPSPs were 
measured in the CA1 every 30 sec after electric stimulation in SC afferents before and after induction 
of LTP. As shown in Fig. 14, the magnitude of LTP at 40 min after the induction was not significantly 
different between the two genotypes tested (p>0.05), showing that early-phase LTP was not affected 





Figure 14. Early-phase long-term potentiation (E-LTP) in Ambra1+/+ and Ambra1+/- mice of both 
sexes in CA1 Stratum radiatum stimulated by Schaffer Collateral 
Graphs of fEPSP normalized to the average value of baseline before and after applying electronic 
shock, 100 Hz for 1 s in both genotypes in male (M) and female (F) at A, B: 21-23 days (M_WT: 5/2, 
M_Het: 12/3, F_WT: 16/5, F_Het: 16/5, slices number/animal number) and C, D: 4 weeks old (M_WT: 
18/4, M_Het: 15/4, F_WT: 12/3, F_Het: 9/3, slice number/animal number); Mean±SEM presented; 






3.5.2 Gamma oscillation 
 
Figure 15. Kainate-induced gamma oscillation in the Stratum pyramidale of CA3 in 
hippocampus 
A, E: Representative trace before and after application of kainate in the CA3 pyramidal layer of 
hippocampus in (A) Ambra1+/+ and (E) Ambra1+/- mice in female (F) and male (M) at 4 weeks old. B, F: 
Representative power spectrum before and after induction in (B) Ambra1+/+ and (F) Ambra1+/- mice in 
female and male at 4 weeks old. C, D, G, F: Peak frequency and average power of gamma oscillation 
within the range of 25-45 Hz of two genotypes in (C, D) female (F_WT: 28/4, F_Het: 27/4, slice 
number/animal number) and (G, H) male (M_WT: 12/3, M_Het: 12/3, slice number/animal number) at 
4 weeks old. I, J: (I) Frequency and (J) average power of gamma oscillation in two genotypes of 
female at 3 weeks old (P21-27) (F_WT: 23/4, F_Het: 24/4, slice number/animal number). H: Graph of 
ratio between average power of Ambra1+/- versus mean of average power of Ambra1+/+ littermate by 
date in female (F_WT; P23: 10/2, P26: 7/1, P27: 6/1, >P28: 28/4; F_Het; P23: 11/2, P26: 8/1, P27: 5/1, 
>P28: 27/4, slice number/animal number); Mean±SEM presented; 
 
In the present study, kainate (100 nM)-induced gamma oscillation in the CA3 pyramidal layer of 
hippocampus in acute brain slice was measured in Ambra1+/+ and Ambra1+/- littermates of both sexes. 




45 Hz) were calculated by subtraction between each 10 minute-epoch of long-lasting and stable 
gamma oscillation and baseline. In female mice of 3 weeks old (P23-P27), the frequency and power of 
gamma oscillation was no different between Ambra1+/- and WT control (Frequency; F_WT: 
32.69±0.6453 Hz, F_Het: 33.19±0.5442, p=0.5517; Power; F_WT: 135.1±42.11 μV2/Hz, F_Het: 
205.5±54.68 μV2/Hz, p=0.3133). However, when analyzing the ratio between the power of Ambra1+/- 
females and the mean of power in control by each day, it was dramatically reduced by day (Fig 15. I-
K). As shown in Fig 15. H, the power of gamma oscillation in Ambra1+/- females was two-times greater 
than control at age P23, but P27 it is reduced to approximately 1/3 of the control value (Fig 15. K). 
Therefore, the same experiment was carried out in 4 week-old (P28-34) females and males of both 
genotypes. There was no difference in frequency of gamma oscillation between genotypes (F_WT: 
32.07±0.7874 Hz, F_Het: 32.27±0.7011 Hz, p=0.8626), while the power in Ambra1+/- females was 
significantly lower compared to control littermates (F_WT: 147.5±35.84 μV2/Hz, F_Het: 46.35±10.42 
μV2/Hz, p=0.0101) (Fig 15. A-D). In the 4 week-old males, both frequency and power of gamma 
oscillation were unchanged (Frequency; M_WT: 32.93±0.8300 Hz, M_Het: 31.50±0.8768 Hz, 
p=0.2481; Power; M_WT: 107.1±19.37 μV2/Hz, M_Het: 94.08±15.36 μV2/Hz, p=0.6052) (Fig 15. E-H). 
Taken together, our results indicate that Ambra1 is involved in sex-specific neuronal network 
regulation, especially in the course of development. 
3.6 Seizure propensity 
 
For further characterization of Ambra1+/- mice as mouse model of autism, we were interested in the 
comorbidity in ASD. The common comorbidity in patients with autism spectrum disorder (ASD) is 
epilepsy at 20 %. In the next experiment, we checked the seizure susceptibility in our animal model of 
ASD, Ambra1+/- mice. The administration of PTZ, a GABAA receptor antagonist, is routinely used to 
test seizure susceptibility (tonic-clonic seizures) in animal models. Low doses (e.g. 20-30 mg/kg) of 
PTZ in rodents cause episodes of generalized spike-and-wave discharge (SWD) on an EEG 
associated with behavioral arrest (MCLEAN et al., 2004; Tabuchi et al., 2007). Higher doses (i.g. 50-
85 mg/kg) induce convulsive seizures with generalized tonic-clonic motor activity (Chiu et al., 2008; 





Figure 16. Seizure propensity induced by intraperitoneal injection of Pentylenetetrazol 
(50mg/kg) in Ambra1+/+ and Ambra1+/- mice of both sexes in different time point 
Latency to first whole body and seizure score of 23-25 day-old A: female (F) and C: male (M) and 12-
13 week-old B: female and D: male; E: Frequency of tonic-clonic, duration of whole body and F: 
percentage of survival in 13 month-old female. p-value and x2 were obtained from survival analysis; 
Mean±SEM presented; n numbers of each group are shown in the figures. 
 
The susceptibility to PTZ-induced seizures in higher doses was evaluated in juvenile, adult and aged 
mice (P23-25, 12-13 weeks old and 13 months old, respectively) in males and females of both 
genotypes (50 mg/kg). In juvenile mice, before hitting puberty, Ambra1+/- females showed resistance to 
PTZ-induced seizures compared to control females, measured by a slower latency to the first whole 




seizure score (F_WT: 2.907±0.1949, F_Het: 1.924±0.3980, p=0.0436) (Fig 16. A), while no genotype 
difference was found in either male genotypes (Latency to first whole body; M_WT: 215.1±21.70 sec, 
M_Het: 350.8±98.54 sec, p>0.05; Seizure score; M_WT: 3.307±0.3010, M_Het: 2.650±0.7724, 
p>0.05) (Fig 16. B). This resistant phenotype in females completely reversed in adulthood (12-13 
weeks old). The seizure response of Ambra1+/- females was higher than that in WT animals, with a 
faster latency to the first whole body episode (F_WT: 537.0±84.53 sec, F_Het: 140.3±18.25 sec, 
p=0.0004) and higher seizure score (F_WT: 1.848±0.2731, F_Het: 4.915±0.3412, p<0.0001) (Fig 16. 
C). Like in the earlier developmental stage, adult males had not difference between two genotypes in 
both parameters (Latency to first whole body; M_WT: 307.0±83.45 sec, M_Het: 304.1±60.88 sec, 
p>0.05; Seizure score; M_WT: 2.979±0.3841, M_Het: 3.017±0.2696, p>0.05) (Fig 16. D). In aged mice, 
this seizure phenotype in Ambra1+/- females became severe by an increase in the number of tonic-
clonic episodes (F_WT: 2.944±0.7351, F_Het: 49.18±14.82, p=0.0325) and longer duration of whole 
body episodes (F_WT: 0.3333±0.2108 sec, F_Het: 1.667±0.4944 sec, p=0.0110) (Fig 16. E). 
Furthermore, 4 mice out of 6 female Ambra1+/- died during the observation, shown in the survival 
analysis in Fig 16. E. 
3.7 Neuronal number and morphology 
Ambra1 does not play a role in regulating activity-dependent synaptic transmission. The difference in 
the power of gamma oscillation could be caused by an imbalance in excitation/inhibition of network 
activity.  To test this, cell morphology and populations of different cell types were assessed. This 





Figure 17. Counting excitatory and inhibitory neurons in the pyramidal layer of hippocampus 
The coronal sections which contain hippocampus region were stained using CTIP2, GAD67 and PV 
antibodies. The representative staining pictures of A: co-staining of CTIP2+ and GAD67+ cells and F: 
single staining of PV+ interneurons in the pyramidal layer of hippocampus are shown with zoomed-in 
version. The densities of B: CTIP2+, C: GAD67+ and G: PV+ cells in the pyramidal layer of 
hippocampus were calculated in Ambra1+/+ and Ambra1+/- female mice of 23 days old. The D: sum and 
E: ratio of CTIP2+and GAD67+ cells, indicatives of total number of neurons and ratio between 
excitation and inhibition, were calculated and compared. 6 animals with 3 sections each per group 
were used for analysis. Mean±SEM presented. 
3.7.1 Neuronal number (Counting of CTIP2+, GAD67 and PV+ cells) 
The populations of neurons in 23-day old Ambra1+/+ and Ambra1+/- female mice were counted using 
CTIP2 for glutamatergic neurons and GAD67 for GABAergic neurons in the CA1 region and PV for 
PV-positive neurons for the pyramidal layer of hippocampus. Fig 17. A and F show the representative 
images of CTIP2-, GAD67- and PV-expressing cells. The numbers of CTIP2+ and GAD67+ cells in 
CA1 were not different between two genotypes (CTIP2+; F_WT: 9619±689.5 cells/mm2, F_Het: 
8680±820.3 cells/mm2, p=0.4015; GAD67+; F_WT: 93.87±9.334 cells/mm2, F_Het: 101.4±13.52 
cells/mm2, p=0.6572) (Fig 17. B and C). Moreover, the sum and ratio of CTIP2+ and GAD67+ cells 
which might be indicators of the total number of neurons and the ratio between excitation and 




F_Het: 8781±1068 cells/mm2, p=0.4037; Ratio; F_WT: 105.4±9.104, F_Het: 98.54±21.54, p=0.7766) 
(Fig 17. D and E). PV+ cells, a subpopulation of interneurons, are well known to modulate gamma 
oscillation in hippocampus (Sohal et al., 2009). However, the number of PV+ cells did not differ 
between Ambra1+/+ and Ambra1+/- females (F_WT: 26.90±1.437 cells/mm2, F_Het: 26.57±1.415 
cells/mm2, p=0.826) (Fig 17. G). 
3.7.2 Neuronal morphology  
To study the properties of pyramidal neurons which induce the phenotype in gamma oscillations by 
reduction of Ambra1 protein, we investigated the neuronal morphology such as dendritic arborization 
and spine analysis. GFP construct was transfected into the pool of hippocampal progenitors at E14.5. 
Quantitative analysis of dendritic arborization and spine analysis was done with 3D reconstruction by 




3.7.3 Dendritic arborization 
 
Figure 18. 3D sholl analysis of CA1 pyramidal neuron - I 
A: Representative picture of CA1 pyramidal neuron in Ambra1+/+ and Ambra1+/- mice in male and 
female at P28, B-G: Comparison of length of whole, apical or basal dendrites in every 10 μm between 
both genotypes in male (M) and female (F); Mean±SEM presented; (slice number/animal number; B: 
M_WT: 11/2, M_Het: 9/3; C: F_WT: 12/3, F_Het: 9/4; D: M_WT: 12/2, M_Het: 9/3; E: F_WT: 11/2, 







Figure 19. 3D sholl analysis of CA1 pyramidal neuron - II 
A-F: Comparison of accumulative number of branching points in whole, apical or basal dendrites in 
every 10 μm between both genotypes in male (M) and female (F); B-G: Comparison of length of whole, 
apical or basal dendrites in every 10 μm between both genotypes in male (M) and female (F); 
Mean±SEM presented; (slice number/animal number; A: M_WT: 11/2, M_Het: 9/3; B: F_WT: 12/3, 
F_Het: 9/4; C: M_WT: 12/2, M_Het: 9/3; D: F_WT: 11/2, F_Het: 9/4; E: M_WT: 11/2, M_Het: 9/3; F: 
F_WT: 12/3, F_Het: 8/4) 
 
The quantification of dendritic arborization in the CA1 pyramidal cells from 28 day-old mice from both 
genotypes and sexes was exploited by 3D Sholl analysis using NeuronStudio. Representative pictures 
of CA1 pyramidal neurons from both genotypes in male and female are displayed in Fig 18. A. The 
analysis of dendritic length (Fig 18. B-G) and number of branching points (Fig 19. A-F) was broken 
down into three parts: apical, basal, and whole cell, and was measured every 10 μm and plotted. 
There was no difference in any of these three regions in both sex and genotype, indicating that 





Autism or ASD is a heterogeneous disorder, as patients exhibit a wide range of symptoms, severity 
and prognosis, which is induced by hundreds of identified causes or potential causal genetic variants. 
Despite the unknown etiology of ASD, monogenic heritable forms of the disorder allowed to develop 
genetic mouse models with proven autism construct validity to investigate the mechanism of ASD 
(Tabuchi et al., 2007, Jamain et al., 2008, Etherton et al., 009, Radyushkin et al., 2009, Berkel et. 
2010). 
We detected an interesting mouse model of ASD, Ambra1+/- mice. Although Ambra1 was found to be 
essential for function of autophagy, unexpectedly, we found it associated with autistm-like symptoms, 
including deficits in social interaction and communication, repetitive behaviors and cognitive rigidity. 
Most strikingly, this phenotype was restricted to females (Dere et al., 2014). However, a causal link 
between Ambra1 protein and the development of ASD has remained obscure. Therefore, I further 
characterized Ambra1+/- mice in order to better understand neural mechanisms of its phenotype at the 
circuitry and cellular level. 
4.1 Neonatal development and communication function 
Autism is diagnosed in children before the age of three in humans. Several studies have reported that 
autistic patients already showed sign of developmental abnormalities before diagnosis. For example, 
in ASD high-risk infants, subtle and repetitive movements or unusual sensory behaviors start earlier in 
development than impairments in social and communication skills (Rogers, 2009). Delay in early motor 
development such as gait abnormalities and difficulties with motor coordination have been consistently 
found as prominent neurological co-morbid conditions in autistic patients (Bhat et al., 2011; Maski et 
al., 2011; Provost et al., 2007). Mecp2 mutant mice modelling Rett syndrome revealed abnormal 
neurodevelopment, such as delay of reflex maturation and of wire suspension performance as a 
neuromotor coordination readout (Bodda et al., 2013). Therefore, the observation of neonatal 
development, including physical development, reflex acquisition and fine-tuned neuro-motor 
coordination, was performed for further characterization of the Ambra1+/- mice as a mouse model of 
autism. Indeed, the neonatal development of Ambra1+/- mice in physical and neurological manners 




Isolation-induced USV of mouse pups by separation from their mothers are considered as a 
quantifiable behavior experiment relevant to ASD (Scattoni et al., 2009). For instance, pups of Tsc2+/- 
and Eif4ebp2 knockout mice, known genetic mouse model of ASD, displayed enhanced USV (Tsai et 
al., 2012; Young et al., 2010), while juveniles of Nlgn4-/- mice produced less USV (Ju et al., 2014). 
Therefore, recording of isolation-induced USV was performed on male and female Ambra1+/+ and 
Ambra1+/- pups to investigate the onset of communication deficits in early age. Interestingly, our data 
showed that at P8-9, Ambra1+/- female pups had a reduction in the number of calls in comparison to 
WT (Fig 7. E, G), while male pups displayed WT USV behavior (Fig 7. F, H). This indicates that 
communication deficits phenotypically described in adulthood of Ambra1+/- females have an earlier 
onset than previously thought. 
4.2 mRNA and protein expression of Ambra1 
In order to investigate the apparent sex-dependent ASD-like phenotype in Ambra1 mutant mice, the 
mRNA and protein level of Ambra1 was extracted from cortical tissue and measured. There was a 
50% reduction in Ambra1 mRNA levels extracted from the cortices of both male and female Ambra1+/- 
when compared to WT littermates (Fig 8. A). Between males and females, that was comparable in 
same genotype. Ambra1 protein levels were also reduced in Ambra1+/- group compared to Ambra1+/+ 
but the reduction between two genotypes was relatively more in females compared to males (Fig 8. C). 
This difference might be due to substantially increased expression of Ambra1 protein in female WT 
mice compared to males, greater requirement of this protein in basal condition in females (Fig 8. D). 
Although the present study has not investigated the mechanism behind the different expression of 
Ambra1 between males and females, several proposals can be suggested to explain a sex-dependent 
expression of Ambra1 protein. The differences in protein expression levels may be due to two 
mechanisms, increase in synthesis and/or decrease in degradation of the protein. First of all, it is 
possible that the translational control of Ambra1 mRNA might be sex-dependent according to its needs. 
Moreover, the translational pathway is known to be one of the mechanism for ASD etiology via eIF4E 
which is regulated by mTOR (Gkogkas et al., 2012; Santini et al., 2012). Ambra1 is able to bind 
directly to mTOR which is regulated by PTEN (Nazio et al., 2013). Since PTEN is able to bind to 
estrogen receptor α (ERα), mTOR-dependent protein synthesis might be affected by estrogen (Briz 




Another possible explanation behind the increase of Ambra1 expression in female mice is the slower 
degradation of Ambra1 protein in female under certain physiological conditions. Studies on the 
degradation of Ambra1 revealed triggering by proteolytic degradation regulated by caspase and 
calpain under apoptotic stimuli (Pagliarini et al., 2012). Little research has been done showing sex-
specific apoptosis, therefore it is difficult to find connection for the sex-dependent proteolysis of 
Ambra1 protein. 
One of the main functions of Ambra1 is to stimulate autophagic process. Autophagy has been 
implicated in synaptic remodeling in C.elegans (Rowland et al., 2006) and Drosophila (Shen and 
Ganetzky, 2009). A postmortem study of brains from human autists revealed a reduced level of 
autophagic activity yielding markedly reduced synaptic pruning (Tang et al., 2014). However, Ambra1 
might not be an important protein for regulating autophagic processes such as Atg proteins or Beclin1. 
LC3-II level in Ambra1-/- embryonic brain at E14 was reduced by half compared to its WT control 
(Maria Fimia et al., 2007), whereas mutant mice of Atg7-/- which is a key protein in the autophagic 
process had no LC3-II signal (Komatsu et al., 2006). Furthermore, in vitro experiments using GFP-
fused-LC3, genotype-associated difference in LC3 signal was only detected under autophagic 
induction but not in basal condition, meaning that the autophagic process has not been ablated with 
the loss of Ambra1 and it is not a critical protein for autophagy but rather ‘helper’ for controlling 
autophagic process (Maria Fimia et al., 2007). This also provides us possibility that, in addition to 
autophagy, there is another function of Ambra1 in the brain, such as cell proliferation or apoptosis, as 
shown in previous research (Maria Fimia et al., 2007). 
4.3 Very mild brain enlargement, neuronal expression & neuronal 
counting 
Brain enlargement is a consistent finding from independent studies of human autistic children 
(Courchesne and Pierce, 2005; Courchesne et al., 2001, 2003; Fidler et al., 2007; Hazlett et al., 2011; 
Saitoh et al., 2001; Sparks et al., 2002). Increased volume in whole- or sub-region of autists’ brains 
was mainly described in ASD patients aged two to three years (Courchesne et al., 2003; Hazlett et al., 
2011), and after this age, the growth rate of brain slowed more than in clinically normal children, 
resulting in either average or reduced brain volume at an older age (Courchesne et al., 2004; Groen et 




present in autistic children compared to control children (Courchesne et al., 2011). This exencephaly 
was also identified Tsc2+/- mouse, one described mouse model of autism. Therefore, the brain size 
within different ROI, such as whole brain, hippocampus, cerebellum, olfactory bulb and ventricles, was 
assessed in the Ambra1+/- mice in both male and female for additional characterization of this mouse 
line. Ambra1+/- mice had larger whole brain and hippocampus compared to its respective WT control in 
23 day-old males and females and 13 month-old females, while the difference between two genotypes 
was acquired in the ventricle size. The cerebellum was the only region where the enlarged size in 
Ambra1+/- was assessed in females but not in males. Since this increase in the average size of 
Ambra1+/- brain size was 103-110% of both male and female control brains, it can be deemed a ‘mild 
enlargement’ but not significantly increased as a pathological marker (Fig 9.). Given the fact that not 
only females but also males had enlarged brain in Ambra1+/- compared to WT, brain enlargement has 
not been correlated with ASD but one of the features in Ambra1+/- mice. 
To understand the cellular substrate of brain enlargement, the next experiment was to investigate 
where this protein is expressed. Since β-gal was expressed under the promoter of Ambra1 in mutant 
allele and mimic the expression of endogenous gene, it can be used as a reporter protein of Ambra1 
expression (Skarnes et al., 1995). By the X-gal staining, the expression of β-gal was detected in cortex, 
striatum and hippocampus of postnatal brain (Fig 10.). Since this experiment was previously 
performed in this mouse line (Maria Fimia et al., 2007), it was confirmation from previous paper. 
Intriguingly, in this staining, the expression of β-gal in the hippocampus seemed to be pyramidal 
neuron-specific. Therefore, I co-immunostained β-gal, combined and other cellular markers in the 
brain, was performed. The expression of β-gal was co-localized with NeuN, a marker for neuron, and 
not with markers for other cell types in the CNS such as astrocytes, microglia and oligodendrocytes, 
(Fig 11.). The specificity of the co-localization with neuronal markers leads me to conclude that 
Ambra1 is expressed specifically neurons within the CNS. This data may suggest the possibility about 
a novel, neuron-specific function of Ambra1. Due to the fundamental importance of autophagy to be 
expressed in all cells, the molecular components important to this process should, therefore, to be 
expressed in every cell type in the brain. We speculate that Ambra1 might have another role in neuron, 




Another function of Ambra1 protein was the regulation of cell proliferation and apoptosis to control 
their balance. Ambra1-/- embryos showed not only incomplete closure of the neural tube, but also the 
absence of normal ventricular system due to the extensive overgrowth of the proliferative 
neuroepithelium. Analysis of cell proliferation by 5-bromodeoxyuridine (BrdU)-uptake experiment 
revealed a significant increase in the number of proliferating cells at E8.5 but not later developmental 
timepoints, indicating the hyper-proliferation phenotype at the onset of neurulation. Thus, excessive 
apoptosis was present in selected areas of the mutant nervous system from E9.0 onwards (Maria 
Fimia et al., 2007). PP2A, a regulator of cell cycle and mitochondrial Bcl-2, an anti-apoptotic factor, are 
direct binding partners of Ambra1 giving evidence that Ambra1 controls cellular proliferation and 
apoptosis (Cianfanelli et al., 2014; Strappazzon et al., 2011). Based on previous findings, we 
considered that malfunction of Ambra1 to regulate the balance between cellular proliferation and 
apoptosis might affect different neuronal number and/or composition of excitatory and inhibitory 
synaptic inputs, consequently changing the function of neuronal networks. 
Therefore, the number of neuron was counted in the hippocampus where the brain volume size had 
the greatest increase between mutant and WT. However, there was no difference in the number of 
excitatory and inhibitory neurons in the pyramidal layer of hippocampus between two genotypes (Fig 
17. B, C). I found no change in the balance of excitation and inhibition based on cell counts in mutant 
hippocampi (Fig 17. D, E). Additionally, the number of PV+ neurons that initiate and regulate gamma 
oscillations remained unchanged in the mutants (Fig 17. G) (Sohal et al., 2009). In conclusion, Ambra1 
might not disturb the balance of proliferation and apoptosis in the brain of Ambra1+/-. Also, such subtle 
increase in brain size in Ambra1+/- could not reflect the change in neuronal number and composition. 
4.4 The effect of Ambra1 on synaptic plasticity 
Synaptic plasticity is the activity-dependent modification of strength and efficacy of synaptic 
transmission. It mainly explains sensory adaptation, learning and memory but the real meaning is the 
neuro-adaptations such as enhanced or depressed synaptic transmission that result from a wide range 
of environmental stimuli. As described previously, synaptic plasticity can be categorized by the 
duration of enduring the activity-dependent change; short-term plasticity and long-term plasticity. 
Short-term facilitation is due to residual Ca2+ from the first stimulus which contributes to a second, 




like plasticity in humans has been shown. It has been reported that several genetic mouse models of 
ASD, such as Tsc1/2, MecP2, Shank2 and Shank3 mutants, display deficits in paired-pulse ratio or 
LTP, suggesting that impairment in synaptic plasticity property may be a milestone to explain their 
autism-like behaviors (Bateup et al., 2013; Bozdagi et al., 2010; Kirschstein, 2012; Na et al., 2013; 
Schmeisser et al., 2012; Wang et al., 2011). Mecp2 mutant mouse is very exemplar mouse model of 
ASD which exhibited disruption in the synaptic plasticity in both forms. For instance, loss-of-Mecp2 
function showed reduced paired pulse ratios, while gain-of-Mecp2 function augmented paired pulse 
responses (Asaka et al., 2006; Collins et al., 2004; Moretti et al., 2006; Na et al., 2012; Nelson et al., 
2006). Moreover, the profound attenuation of Schaffer-collateral LTP and LTD are displayed in 
symptomatic Mecp2 null mice, whereas Mecp2 overexpression mouse lines showed enhanced 
hippocampal LTP (Asaka et al., 2006; Moretti et al., 2006; Weng et al., 2011). Taken together, it was 
suggested that Mecp2 might either affect or be affected by Ca2+ in the presynaptic terminal or perhaps 
may alter proteins involved in neurotransmitter release (Na et al., 2013). Tsc2+/- rats showed impaired 
LTP and LTD, implying that the protein synthesis in the mTOR signaling which is regulated by Tsc2, 
will control synaptic plasticity (Kirschstein, 2012). Different mutant mouse of Shank2 and Shank3 
showed impairment in NMDAR-dependent LTP and LTD, which can be explained by the effect of 
Ca2+-mediated calpain signaling on the Shank-actin connection, important in NMDAR-LTP (Yoo et al., 
2014). Therefore, we studied the activity-dependent synaptic plasticity in Ambra1+/+ and Ambra1+/- 
mice in both male and female of 3 and 4 weeks old. Surprisingly, the short-term and the long-term 
synaptic plasticity in Ambra1+/- didn’t change compared to its WT in both sexes of 3 and 4 weeks old 
(Fig 13, Fig 14). This is in line with normal learning and memory behavior test in this mouse line (Dere 
et al., 2014). Therefore, autistic phenotypes shown in Ambra1+/- have no relationship with synaptic 
plasticity, activity-dependent modification of synaptic strength, suggesting that Ca2+-dependent 
signaling and the AMPA/NMDA receptors is not related with Ambra1 and not involved in ASD. 
4.5 Seizure phenotype, gamma oscillations and E/I balance 
Psychiatric disorders are mostly caused by the abnormal functions of neurons which mainly originate 
from two main reasons: neuronal degeneration and network disturbance. The effect of neuronal 
degeneration on psychiatric disorders is well studied, especially in Alzheimer’s disease (Cárdenas et 




disturbance of neural network might induce psychiatric disorders, including ASD. Although the 
neurophysiological substrates of ASD are poorly understood, several studies with different monogenic 
mouse models proposed different speculations to explain the etiology of ASD in terms of disturbance 
in neural network (O’Donovan et al., 2009; Pardo and Eberhart, 2007; Patterson, 2011; Südhof, 2008). 
One emerging hypothesis is that imbalance between excitation and inhibition (E/I) could affect the 
deficit in the social and cognitive functions which are important features in autism (Kehrer et al., 2008; 
Lee et al., 2016; Markram and Markram, 2010). Recording gamma oscillation and induction of seizure 
are two appropriate tools to study the alteration of E/I balance in neural network.  
Firstly, gamma oscillation was induced by the application of kainate in the acute brain slice of 
Ambra1+/+ and Ambra1+/- mice of male and female in 3 or 4 weeks old. Our data showed that the 
power of gamma oscillation (γ-power) in Ambra1+/- females was lower than that in Ambra1+/+ female at 
the age of 4 weeks (Fig 15. D), whereas this reduction was not detected in 3 week-old female mice 
(Fig 15. J). By calculating the ratio of γ-power between Ambra1+/- and Ambra1+/+ by date, it was 
revealed that γ-power of Ambra1+/- was approximately two times more than that of Ambra1+/+ at P23, 
and this ratio was decreased until P27 when this power was less than Ambra1+/+ γ-power (Fig 15. K). 
However, the male mice showed similar γ-power between two genotypes in 4 weeks old (Fig 15. H), 
meaning that gamma oscillation might be indicative for ASD. Opposite pattern of data in female of 3 
and 4 weeks old might provide evidence of Ambra1 function, since the period of 3 weeks is very 
critical point for synaptic pruning or sexual maturation in mice. 
Since this E/I imbalance is correlated with the seizure phenotype, which is one of the co-morbid 
conditions of ASD, the measurement of seizure propensity in mouse model is another tool to study this 
imbalance. Moreover, a recent study using neuron-specific Ube3a mutant mouse demonstrated the 
association between neural oscillations measured by EEG and seizure susceptibility (Judson et al., 
2016). Therefore, the seizure propensity was assessed in Ambra1+/+ and Ambra1+/- mice of male and 
female by i.p. injection of PTZ, agonist of GABAA receptor, in different ages. In the present study, 
Ambra1+/- females at P23-25 showed the later onset of whole body seizure and lower seizure score 
compared to control, indicating less seizure propensity (Fig 16. A), whereas at 12-13 weeks old, these 
mice exhibited significantly faster onset of whole body seizure and higher seizure score than control 




these two-time periods, male mice didn’t show any difference between both genotypes (Fig 16. B, D). 
This is correlated with higher incidence of the later seizure onset in human ASD, approximately after 
10 years old (Volkmar and Nelson, 1990). Furthermore, in very old age, 13 months old, the genotype-
associated difference of seizure propensity in female developed more severe by more number of tonic 
and clonic episodes and longer duration of whole body seizure (Fig 16. E). Even, 4 out of 6 Ambra1+/- 
females died during this experiment, showing severe seizure propensity (Fig 16. F). In the end, our 
data of gamma oscillation and seizure phenotype are correlated with each other, pointing to the E/I 
imbalance in Ambra1+/- females. In detail, these data provide three points to discuss about; 1) 
genotype-associated difference, 2) sex-dependent difference, 3) age-dependent difference of E/I 
balance. 
The causal factors of E/I imbalance should be considered for the etiology of these differences. This E/I 
imbalance, an indicative of change in excitatory and inhibitory inputs, can be caused by alteration 
either in the neuronal cell number or in neuronal morphology, such as dendritic morphology or spine 
numbers. Our previous data already showed no difference of excitatory and inhibitory cell numbers in 
hippocampus between two genotypes. Moreover, the number of PV+ neuron, the main cause of 
synchronized oscillation, (Sohal et al., 2009) was not altered. Therefore, the etiology of E/I balance by 
the functional deficiency of Ambra1 should be studied for the next step. Sex- and age-dependent 
differences of E/I balance will be explained in detail in Section 4.7.  
4.6 Dendritic arborization & spine number 
The genetic factors of ASD involve the genes encoding postsynaptic regulatory proteins, as well as 
scaffolding proteins and synaptic receptors (Muhle et al., 2004). The activity of these regulatory 
proteins can be triggered by external stimuli or controlled by intrinsic factors. Since there was no 
change in synaptic plasticity in Ambra1+/- compared to control animals, change in the E/I balance in 
Ambra1+/- mice is likely to result from independent factors of external stimuli. The morphological 
change in the neuron, such as dendritic arborization or spine number, will affect the entire synaptic 
input. 
Dendrite morphology is a hallmark of the neuron and it has important functions in defining which sort 




decades, transcription factors, local translational machinery, regulation of cytoskeletal elements, 
vesicle trafficking and various signaling pathways have been identified to regulate dendritic 
arborization of individual neurons and the integration of these dendrites into the neuronal circuitry. The 
dendritic arborization has been investigated in the ASD (Ramocki and Zoghbi, 2008). The genetic 
mouse model of Mecp2 overexpression exhibited dendritic overgrowth in cortical pyramidal neurons 
(Jiang et al., 2013). Additionally, Pten, deletion of which produced autism-like behavior, is known to 
regulate neurite growth (Hsia et al., 2014; Lugo et al., 2014). The major structural components that 
underlie dendritic morphology are actin and microtubule. Any factors which modulate the actin and 
microtubule dynamics or the transport of building elements and organelles to the dendrites play 
important roles in the dendritic morphogenesis. Given that Ambra1 is binding to the microtubule in the 
basal condition via its dynein binding domain (Di Bartolomeo et al., 2010), it is possible to hypothesize 
that Ambra1 might be involved in the dendritic morphogenesis. Therefore, the quantification of 
dendritic arborization was performed in the CA1 pyramidal neurons of hippocampus in Ambra1+/+ and 
Ambra1+/- at P28, when the reduced γ-power was detected. GFP construct was sparsely 
electroporated at E14.5 into the hippocampal precursor cells, which allowed us to analyze single 
pyramidal neuron by the reconstruction of dendrite and sholl analysis in Neuronstudio program. 
However, there was no significant difference in dendritic length and branching point in apical, basal 
and total dendrites of CA1 pyramidal neurons between two genotypes, suggesting that Ambra1 might 
not regulate the dendritic growth (Fig 18, Fig 19). Therefore, the number of spines or 
electrophysiological recording of single pyramidal neuron should be considered in order to measure 
excitation and inhibition for the next step. As increased synaptic density in the cortical pyramidal 
neurons was reported the postmortem brain of human autists, it is important to study the synaptic or 
dendritic spine number in Ambra1+/- to study neural mechanism of gamma oscillation. Currently, single 
cell patch-clamp recording of hippocampal pyramidal neurons is on-going both in acute brain slice and 
in autaptic culture in order to compare the number of functional excitatory and inhibitory synapses 
between genotypes. The culture of autaptic neurons in this study was established at E14 to enable to 
study Ambra1 null mutation. In this culture system, the neuron of Ambra1-/- was able to survive and 
grow normally, meaning that Ambra1 might not critically regulate on the neuronal development. In 
acute brain slice, CA1 and CA3 pyramidal neurons will be filled with biocytin during patch-clamp 




4.7 Female-specific ASD 
So far, it is still unclear why Ambra1+/- shows genotype-associated phenotype, such as autism-like 
behavior, gamma oscillation and seizure, only in female. However, as I mentioned before, our data 
and other previous literature provides evidence to discuss in several ways. 
One possible mechanism for sex-dependent phenotype in Ambra1+/- is the relationship between 
Ambra1 and estrogen which was mentioned previously. Different pattern of mRNA and protein 
expression in the present study gave possible explanation that the sex-dependent control of Ambra1 
translation is able to exist. The relationship PTEN and estrogen might regulate mTOR, which is an 
upstream regulator of Ambra1 and involved in regulating local protein synthesis and cytoskeletal 
reorganization via eukaryotic translation initiation factor 4E (eIF4E), in sex-dependent manner (Briz 
and Baudry, 2014; Yu and Henske, 2006). Moreover, the translational pathway through eIF4E is 
known to be one of the mechanisms for ASD etiology (Gkogkas et al., 2012; Santini et al., 2012). 
However, this eIF4E translational machinery plays an important role in the process of sex 
determination in Drosophila melanogaster, which is not controlled by sex hormone, by regulating Sex 
lethal (Sxl)-dependent female-specific alternative splicing of the male specific lethal-2 (msl-2) and Sxl 
translation, without any effect of sex hormones (Graham et al., 2011). Therefore, Ambra1 translation 
from mRNA to protein might be regulated in sex-specific manner dependent or independent of sex 
hormone. 
Another genetic mouse model of autism which shows sex-dependent autism-like behavior is Activity-
dependent neuroprotective protein (ADNP) haploinsufficient males, while its females showed cognitive 
decline in later age like Alzheimer’s disease (Malishkevich et al., 2015). It is consistent with our mouse 
model because their sex-specific phenotype was coming from different expression of protein between 
males and females. ADNP is part of SWI/SNF chromatin remodeling complex including BAF57 that 
specifically regulates ERα-mediated transcription. Interestingly, this protein was able to bind to eIF4E 
which regulate protein translation and is one of the candidate proteins for ASD by regulating the 
synaptic protein expression, such as neuroligin. 
Intriguingly, our data about the higher propensity of seizure and reduced γ-power in Ambra1+/- females 




is a puberty period when the sexual maturation starts and the synaptic pruning takes place. This 
enables us to speculate that the number of excitatory or inhibitory synapses was altered in Ambra1+/- 
mice which could cause the difference in gamma oscillations. A number of studies showed the 
mechanism of pubertal synaptic pruning dependent or independent of sexual hormones, such as 
estradiol or testosterone (Afroz et al., 2016; Oren-Suissa et al., 2016; Yildirim et al., 2008). 
One recent study using diffusion tensor imaging in human brains showed different neural networks 
between males and females as well as sex-dependent development of brain connectivity during 
pubertal period. For example, during development, male brains are structured to facilitate within-lobe 
and within-hemisphere connectivity, whereas female brains have greater inter-hemispheric 
connectivity and greater cross-hemispheric participation (Ingalhalikar et al., 2014). This might explain 
the sex- and age-dependent difference of γ-power in females of our mouse line. I speculate that 
certain genetic mutation might help exceeding a threshold to induce psychiatric disorders in one sex, 
whereas in the other sex, this mutation is not effective due to different brain connectivity. Similarly, 
Ambra1 haploinsufficiency is enough to trigger ASD, seizure propensity and reduced γ-power only in 
female animals, but not in males. 
Surprisingly, a recent research has revealed sex-specific pruning of neuronal synapses in C.elegans. 
The nervous system of C.elegans containing sex-specific neurons and sex-shared neurons found in 
both hermaphrodite and male organisms gave a crucial evidence of sex-dimorphic regulation of 
neurons independently of sexual hormones. It is shown that sex-shared synaptic wiring patterns were 
utilized in sex-shared neurons in neuron-type specific manner. Moreover, the formation of sex-specific 
synapse arises prior to sexual maturation in the animal which was regulated by sex-specifically 
expressed transcriptional factors, indicating that there is an intrinsic, sex-specific mechanism 
controlling the synaptic pruning independent of sexual hormones (Oren-Suissa et al., 2016). Other 
causal factor for the etiology of sex difference can be considered, such as fT and XY chromosomes.  
Taken together, based on the comprehensive behavioral analysis, the present study characterized the 
brain of Ambra1+/- mice as the genetic mouse model of female-specific ASD in cellular and circuitry 
approach. Ambra1+/- female mice showed phenotype not only in autism-like behavior but also in 
seizure propensity and gamma oscillation compared to its control. Further study should be needed to 
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-/- Knockout 
+/- Heterozygous 
+/+ Wild type 
°C Degrees Celsius 
2D 2-dimention(al) 
3D 3-dimention(al) 
ACSF Artificial cerebrospinal fluid 
ADNP Activity-dependent neuroprotective protein 
Ambra1 Activating molecule in Beclin-1-regulated autophagy (murine) 
AMBRA1 Activating molecule in Beclin-1-regulated autophagy (human) 
Ambra1-/- Ambra1 knock-out 
Ambra1+/- Ambra1 heterozygous 
Ambra1+/+ Ambra1 wild-type 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid  
AMPAR AMPA Receptor 
ARR Air righting reflex 
ASD Autism spectrum disorder 
Atg7 Autophagy related 7 
BAF57 Brahma-related gene 1-associated factor 57 
Bcl-2 B-cell lymphoma 2 
Beclin1 Coiled-coil myosin-like BCL2-interacting protein 
bp Basepair 
BrdU Bromodeoxyuridine 
BSA Bovine serum albumin 
C.elegans Caenorhabditis elegans 
CA Cliff avoidance 
CA1 Cornu Ammonis 1 
CA3 Cornu Ammonis 3 
cm Centimeter 
c-Myc Myc proto-oncogene protein 
CNS Central nervous system 




DLC1/2 Dynein light chains 1/2 
DNA Deoxyribonucleic acid 
dNTP Desoxyribonucleoside triphosphate 
DSM-V Diagnostic and Statistical Manual of Mental Disorders, fifth edition 
DTT Dithiothreitol 
E.Coli Escherichia coli 
E/I Excitation/Inhibition 




EC Entorhinal cortex 
ECL Enhanced chemiluminescence 
EEG Electroencephalogram 
eIF4E Eukaryotic translation initiation factor 4E 
Eif4ebp2 Eukaryotic Translation Initiation Factor 4E Binding Protein 2  
E-LTP Early-phase long-term potentiation 
ER Endoplamic reticulum 
Erα Estrogen receptor α  
ET Ear twitch 
Ex Exencephaly 
F Female 
F_Het Female Ambra1 heterozygous 
F_WT Female Ambra1 wild type 
fEPSP field excitatory postsynaptic potential 
FMR1 Fragile X mental retardation 1 
fT Fetal testosterone 
FV Fiber volley 
g Gram 
GABA Gamma-Aminobutyric acid 
GABAA receptor GABA A Receptor 
GAD67 Glutamate decarboxylase 67 
GC Generalized clonus 
GFAP Glial fibrillary acidic protein 
GFP Green fluorescent protein 
GWAS Genome-wide association study  
Het Heterozygous 
HFS High frequency stimulation 
hr Hour(s) 
HRP Horseradish peroxidase 
Hz Herz 
i.p. Interaperitoneally 
IBA-1 Ionized calcium binding adaptor molecule-1 
IL-2 Interleukin-2 
ISI Interstimulus interval 
kb Kilo basepair 
kg Kilogram 
KO Knockout 
lacZ Bacterial β-galactosidase gene 
LC3 Light chain 3 
LIR LC3-interacting region 
LPP Lateral perforant pathway 
LTD Long-term depression 








M_Het Male Ambra1 heterozygous 
M_WT Male Ambra1 wild type 
mAChRs Muscarinic acetylcholine receptors 
mBcl-2 Mitochondrial B-cell lymphoma 2 
Mecp2 Methyl-CpG binding protein 2 (Murine) 
MeCP2 Methyl-CpG binding protein 2 (Human) 
mg Milligram 
mg Milligram 





MPP Medial perforant pathway 
MRI Magnetic resonance imaging 
mRNA Messenger ribonucleic acid 
msec Millisecond 
msl Male specific lethal-2  
mTOR Mammalian target of rapamycin 
mTORC1 Mammalian target of rapamycin complex 1 
MΩ Mega Ohm 
NeuN Neuronal neuclei 
NF1 Neurofibromin 1 
NGF Negative geotaxis reflex 
NHS Normal horse serum 
NLGN3 Neuroligin 3 
NLGN4X Neuroligin 4 X-linked 
NLGN4Y Neuroligin 3 Y-linked 
nm Nanometer 
NMDA N-methyl-D-aspartate 
NMDAR NMDA receptor 
NRX1 Neurexin 1 
OF Open field traversal 
Olig-2 Oligodendrocyte transcription factor 
P Postnatal day 
PBS Phosphate buffered saline 
PC Partial clonus 
PCR Polymerase chain reaction 
PI3KIII Class III Phosphoinositol-3-kinase complex 
pmol Picomol 
PP Perforant pathway 
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PR Placing response 
Pten Phosphatase and tensin homolog 
PTZ Pentylenetetrazol 
PV Parvalbumin 
PXP PxPxxxR motif in AMBRA1 protein 
qPCR Quantitative polymerase chain reaction 
REM Rapid eye movement 
RNA Ribonucleic acid 
ROI Region of interest 
rpm Revolution per minute 
RT Room temperature 
RT-qPCR Quantitative reverse transcription-polymerase chain reaction 
Sb Spina bifida 
SC Schaffer collateral 
Sc Spinal cord 
SDS-PAGE Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis 
sec Second(s) 
SEM Standard error of means 
Shank2 SH3 and multiple ankyrin repeat domains protein 2 (Murine) 
SHANK3 SH3 and multiple ankyrin repeat domains protein 3 (Human) 
Shank3 SH3 and multiple ankyrin repeat domains protein 3 (Murine) 
SRR Surface righting reflex 
SVZ Sub-ventricular zone 
SWD Spike-and-wave discharge 
SWI/SNF SWItch/Sucrose Non-Fermentable complex 
sxl Sex lethal 
SYN1 Synapsin 1 (Human) 
T Tesla 
T Telencephalon 
TA Temporoammonic pathway 
TAE Tris/acetate/EDTA 
TBST Tris buffered saline/Tween20 
TC Tonic-Clonic 
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